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ABSTRACT 
Higher-order structures in the 5' untranslated region (UTR) of plus-strand 
RNA viruses are known in many cases to function as cis-acting elements in RNA 
translation, replication, and transcription. The bovine coronavirus (BCo V) 210 
nucleotide (nt) 5' UTR is predicted to contain four higher-order structures 
identified as stem-loops I to IV. In this study, evidence supporting the structure 
and a cis-acting function in BCoV defective interfering (DI) RNA replication of 
two of these structures, stem-loops III and IV is presented. Both stem-loops show 
phylogenetic conservation among group 2 coronaviruses and appear to have 
homologs or analogs in coronavirus groups 1 and 3 and in the SARS coronavirus. 
Stem-loop III has in all coronaviruses for which sequence is known a closely 
associated short, AUG-initiated intra-5' UTR open reading frame (ORF). Stem­
loop III in BCoV DI RNA (i) maps at nt 97 through 116, and has associated with 
it beginning at nt 100 an ORF potentially encoding an 8 amino-acid peptide, (ii) 
must maintain stem integrity in the positive and in the negative strands for DI 
RNA replication, (iii) shows a positive correlation between maintenance of the 
short ORF and maximal DI RNA accumulation, (iv) specifically binds in the 
positive strand the 50 kDa viral nucleocapsid protein, and an unidentified viral 
protein of approximately 22 k.Da, and (v) in the negative strand specifically binds 
seven cellular proteins in the range of 76 to 25 kDa. These results indicate that 
stem-loop III might function as a cis-acting element for DI RNA replication 
through interactions in the positive strand with viral proteins and in the negative 
strand with cellular proteins. Stem-loop IV in BCo V DI RNA (i) maps between 
nts 186 and 215, (ii) must maintain stem integrity only in the positive strand for 
DI RNA replication, and (iii) specifically binds eight cellular proteins in the range 
of 75 to 25 kDa. These results indicate that stem-loop IV might function as a cis­
acting element for DI RNA replication through interactions with cellular proteins. 
It is postulated that stem-loops III and IV function similarly in the virus genome. 
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CHAPTER I. LITERATURE REVIEW. 
BACKGROUND 
What are coronaviruses? All animal viruses can be grouped into those that 
have a DNA genome (the DNA viruses), and those that have an RNA genome 
(the RNA viruses). There are seven families of animal DNA viruses, and 
seventeen families of animal RNA viruses. Coronaviruses are one of the 
seventeen families of animal RNA viruses. Each virus family has a distinctive 
virion structure, genome structure, and/or strategy of replication. The coronavirus 
family of RNA viruses has all three distinctive features; they are enveloped 
viruses that have a distinctive 'crown-like' appearance due to their prominent 
surface projections or spikes, hence their Latin name 'corona' (reviewed in Lai 
and Cavanagh, 1997); they have the largest known plus-strand viral RN A 
genome; and they have a unique replication strategy that involves a discontinuous 
transcription step in the production of a 3 '-coterminal nested set of subgenomic 
mRNAs (Fig. 1.1 ). 
Coronaviruses belong to the order Nidovirales, which includes the virus 
families of Arteriviridae and Roniviridae, in addition to the Coronaviridae. 
Coronaviruses cause respiratory, gastrointestinal, hepatic, cardiovascular, and 
neurological diseases in animals, and the bovine coronavirus (BCo V) causes 
diarrhea in calves (Murphy et al., 1999). In humans, coronaviruses have been 
associated with respiratory disease ( common cold) (Holmes and Lai, 1996; 
McIntosh, 1996), and recently with severe acute respiratory syndrome (SARS) 
(Drosten et al., 2003; Ksiazek et al., 2003). 
Coronavirus subgroups. There are three coronavirus subgroups, groups 1, 
2, and 3 ( originally called serogroups) (Lai and Cavanagh, 1997). Some group 1 
coronaviruses are TGEV (porcine transmissible gastroenteritis virus), HCo V-
229E (human respiratory coronavirus-229E), and PEDV (porcine epidemic 
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Fig. 1.1. Schematic depiction of coronavirus replication. Adapted 
from Holmes and Lai, Fields Virology, 1996. Virus entry occurs by 
endocytosis triggered by the interaction of the spike (S) protein with 
the specific receptor on the cell surface. Replication takes place in the 
cytoplasm. Initially the 5' most open reading frame (ORF l a  and b) is 
translated into polyproteins, which are processed to yield the viral 
polymerase and other proteins involved in viral RNA synthesis. The 
viral polymerase then uses the genomic RNA as a template to 
synthesize full-length negative sense RNAs. The negative RNA is 
used as a template for genomic RNA synthesis. Transcription to 
produce an overlapping nested set of 3' coterminal sgRN As 
containing a common leader RNA sequence at the 5' end takes place. 
The leader sequence is depicted by a filled box. Each sgRNA positive 
strand has a negative strand counterpart (Sethna et al., 1989). The 
sgRNA positive strands are translated to produce the N, M, E, S, HE, 
and NS proteins. The N protein packages the genomic RN A into 
helical nucleocapsids. Assembly occurs by budding into the 
endoplasmic reticulum (ER) and Golgi apparatus, virus particles being 
transported to the surface of the cell by the secretory pathway. The S, 
E, HE, and M proteins are glycoproteins that are processed in the ER 
and are then targeted to the Golgi. 
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diarrhea virus). Some group 2 coronaviruses are BCo V (bovine enteric 
coronavirus), HCoV-OC43 (human respiratory coronavirus-OC43), HECoV-4408 
(human enteric coronavirus-4408), HEV (porcine hemagglutinating encephalitis 
virus), ECoV (equine coronavirus), MHV-A59 (mouse hepatitis virus-A59), 
MHV-2 (mouse hepatitis virus-2), and MHV-JHM (mouse hepatitis virus-JHM). 
IBV (avian infectious bronchitis virus) is a group 3 coronavirus. HCoV-SARS 
(human severe acute respiratory syndrome coronavirus) has not been placed in a 
group as yet. 
Coronavirus genome structure. Coronaviruses are plus-strand RNA 
viruses that have the largest known viral RN A genomes (Lai and Cavanagh, 
1997). The complete genomes of seven species of coronaviruses [IBV -Beaudette 
(Boursnell et al., 1987), BCo V-ENT (Chouljenko et al., 2001 ), MHV-A59 
(Leparc-Goffart et al., 1997), HCoV-229E (Herold et al., 1993), TGEV-Purdue 
(Almazan et al., 2000; Eleouet et al., 1995; Penzes et al., 2001), PEDV-CV777 
(Kocherhans et al., 2001), HCoV-SARS (Marra et al., 2003)] have been 
sequenced and reported in GenBank (Fig. 1.2). The complete genome sequences 
of additional strains of BCo V (including the BCo V-Mebus strain sequenced in 
our laboratory), MHV, and HCo V-SARS have also been reported. The genome 
lengths range from 27 ,31 7 nucleotides ( nts) for H Co V-229E to 31,357 nts for 
MHV-A59. The bovine coronavirus�t1ebus strain studied here has a 31,028 nt 
genome that is single-stranded, nonsegmented, and polyadenylated at the 3' end 
(Fig. 1.2, Fig. 1.3 A). It has a 210 nucleotide (nt) 5' untranslated region (UTR). 
Nucleotides 1 through 65 in the 5' UTR are called the leader region. The leader 
also forms the 5' ends of all the bovine coronaviral subgenomic mRNAs. The 
bovine corona virus has a 3' UTR that is 288 nts long, exclusive of the poly[ A] 
tail. In the genome, the genes are arranged in the order 5 '-polymerase ( from 
ORFs la and lb)- spike glycoprotein (S)- small membrane protein (E)­
membrane glycoprotein (M) - nucleocapsid protein (N) - 3'. Several additional 
open reading frames (ORFs) are interspersed among these genes. These 
3 
Fig. 1.2. Genomes of the seven sequenced species of coronaviruses. Adapted 
from Brian, 2003, with permission. The SARS genome was adapted from Ruan et 
al., 2003, and Snijder et al., 2003. Maps are drawn to approximate scale and 
species are shown in decreasing order of size within each of the three groups. 
Since the SARS coronavirus has not been placed in a group as yet it is shown in a 
separate group from the rest of the coronaviruses (group 4 ). The representations 
are derived from data in the GenBank. For gene 1 (ORFs la and lb) the predicted 
protease cleavage sites are indicated by numbers and domains of known or 
predicted function are shaded and identified (PL, papain-like protease; 3CL, 
poliovirus 3C-like protease; TM, transmembrane domain; RdRp, RNA-dependent 
RNA polymerase; Z, zinc finger (metal-binding) domain; Hel, helicase domain; 
C, conserved sequence domain; SUD, SARS coronavirus unique domain). Genes 
2-8 ( or 9) are identified by their transcript name ( 1 a, 1 b, etc.) or their abbreviated 
name of the protein product (S, spike; E, envelope; M, membrane; N, 
nucleocapsid; HP, hydrophobic protein; HE, hemagglutinin-esterase; I, internal). 
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Fig. 1 .3. Observations that led to this research. A. Schematic 
depiction of the BCoV genome, the BCoV DI RNA, and the cloned 
DI RNA (pDrepl). pNrep2 is a clone of mRNA7 containing the 
same 30-nt reporter sequence as pDrep 1.  Also shown are the 
Northern assay replication results. VPl denotes virus passage one 
on fresh cells, and indicates progeny virus RNA packaging. B. 
Schematic depiction of the 421 nucleotide difference between 
replicating pDrep 1 and non-replicating pNrep2 (Chang et al. , 1 994 ). 
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additional ORFs encode non-structural proteins of unknown functions. For 
BCo V, 18 nonstructural and 8 structural proteins have been predicted (Fig. 1.2). 
Coronavirus replication. Shown in Fig. 1.1. The first step in viral 
infection is the interaction of the spike (S) protein with the specific receptor on 
the surface of the host cell. The BCo V receptor is 9-O-acetylneuraminic acid 
(Popova et al. , 2002; Schultze et al. , 1993 and 1994). Virus entry into the host 
cell occurs by endocytosis that is brought about by the S protein mediated fusion 
of the viral envelope with the cellular plasma membrane or endosomal 
membranes. Coronavirus replication takes place entirely within the cytoplasm of 
infected cells. Initially the 5' most open reading frame ORF la and 1 b is 
translated into polyproteins 1 a and 1 ab, that are cleaved during translation to yield 
a viral polymerase (part of gene 1 b codes for the actual viral polymerase), and a 
variety of peptides ( fourteen cleavage proteins, in addition to the polymerase are 
predicted for BCoV, shown in Fig. 1.2; K. Nixon and D. Brian, unpublished), 
most of them having unknown functions (Lee et al. , 1991; Bost et al. , 2000; Sims 
et al. , 2000). The viral polymerase then uses the genomic positive-strand RNA as 
a template to synthesize a full-length, minus-strand copy of the genome (the 
antigenome ). The minus-strand RN A then acts as a template on which the 
positive-strand viral RN A genome is synthesized. In BCo V this step is highly 
asymmetric, since approximately 100 positive strands are produced for every 
negative strand (Hofmann et al. , 1990). In infected cells, viral subgenomic 
mRNAs (sg mRNA) that are polyadenylated at the 3 '  end are also synthesized. 
Coronaviruses synthesize six to eight sg mRNA species of different sizes, 
depending on the coronavirus species and strain (Lai and Cavanagh, 1997). In 
BCoV eight species of sg mRNAs are synthesized. The sg mRNAs form an 
overlapping 3 '-coterminal nested set with the viral genome. The smallest of the 
sg mRNAs (coding for the N protein) contains the 3'-terminal ORF (the N ORF) 
of the genome, and the next larger sg mRNA contains one additional ORF and so 
on. All sg mRN As, except for the smallest, are thus structurally polycistronic, but 
7 
functionally monocistronic ( only the 5' most open reading frame of each sg 
mRNA gets translated; with some exceptions). A distinguishing feature of 
coronaviral and arteriviral sg mRNAs is that their sequence is discontinuous with 
respect to the genome since they contain a common leader sequence which is 
derived from the 5' end of the genome. In BCoV all the sg mRNAs contain the 
65 nt (nts 1 to 65) leader RNA sequence at their 5' end (Hofmann et al. , 1993). 
Though a unique mechanism of discontinuous transcription has been proposed to 
function in bringing the leader RNA sequence and the sg mRNA body together 
(Cavanagh, 1997; de Vries et al. , 1997; Lai and Cavanagh, 1997; Snijder et al. , 
1998; van der Most et al. , 1995), this process has not been fully understood. Each 
sg mRNA is translated to yield only the protein encoded by the 5' most open 
reading frame of the sg mRNA (with exceptions). These proteins include 
structural proteins N, M, E, S, and HE (hemagglutinin-esterase ), and several non­
structural (NS) proteins. The HE protein is not synthesized by all coronaviruses, 
but BCoV synthesizes this protein. The BCoV also synthesizes an I (internal) 
structural protein whose ORF lies entirely within the N ORF (Senanayake et al. , 
1992). The N protein packages the newly synthesized viral genomic RNA into 
helical nucleocapsids. The S, E, HE, and M proteins are glycoproteins that are 
processed in the endoplasmic reticulum and then targeted to the Golgi apparatus. 
Assembly of the virion occurs by budding into the endoplasmic reticulum and 
Golgi apparatus, virus particles being transported to the surface of the cell by the 
secretory pathway. 
Coronavirus defective-interfering (DI) RNA. DI virus particles are 
formed in both RNA and DNA viruses. These are usually found naturally in viral 
stocks that accumulate Dis, which are virus particles that contain genomes that 
have large deletions, usually of essential functions, but that nevertheless retain 
critical replication elements and packaging signals allowing for amplification and 
packaging in co-infections with complementing wild type helper virus (Condit, 
2001 ). Dis usually display a replication advantage relative to wild type virus and 
8 
actively inhibit replication of the wild type virus, presumably by competing for 
limited essential replication factors, hence their name (Condit, 2001 ). Since DI 
RNAs are amplified efficiently by viral polymerases supplied in trans, and are 
shorter than the wild type viral RNA genome making them easier to manipulate 
and study, they are extremely useful as model RNA templates for the 
identification of viral cis-acting replication signals (Ray et al. , 2003), even when a 
full-length infectious cDNA clone of the viral RNA genome has been generated. 
To date, a full-length, infectious cDNA clone of the BCoV RNA genome has not 
been generated. Full-length, infectious cDNA clones of four other coronaviruses, 
TGEV (porcine transmissible gastroenteritis coronavirus) (Almazan et al. , 2000; 
Yount et al. , 2000), HCoV-229E (human coronavirus strain 229E) (Thiel et al. , 
200 1 ), IBV (avian infectious bronchitis virus) (Casais et al. , 2001 )  and MHV-A59 
(mouse hepatitis virus strain A59) (Yount et al. , 2002) have been generated. 
For BCoV, a cloned, naturally occurring 2. 1 3  kilobase DI RNA (Chang 
and Brian, 1 996; Chang et al. , 1 994; Chang et al. , 1 996) (Fig. 1 .3 A) is being used 
for the identification and characterization of cis-acting elements for replication. 
This DI RNA is a fusion of the 5 '  and 3 '  termini of the genomic RNA (the 5 ' ­
terminal 496 nts and the 3 ' -terminal 1 63 7 nts exclusive of the poly[ A] tail, and a 
poly[A] tail of 68 nts). The DI RNA thus has a 5 '  UTR and a 3 '  UTR that are 
identical to those of the BCo V genome. It also has all of the nucleocapsid (N) 
gene fused in-frame to part of gene 1 a, resulting in a single, fused open reading 
frame. The DI RNA does not have gene lb  that codes for the actual viral 
polymerase. This DI RNA undergoes replication in the presence of the BCoV 
helper virus that supplies the viral polymerase and probably other viral proteins 
required for replication. Experimentally, DI RNA replication in helper virus 
infected cells is monitored by Northern assays. For this, a strand-specific probe 
for a 30 nucleotide reporter sequence within the N gene is used. The cloned DI 
RNA construct that has the 30 nt reporter sequence is called pDrep 1 .  
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Cis-acting elements for coronavirus replication. With the use of this and 
other group 2 coronavirus DI RNA genomes, five cis-acting elements for 
replication have so far been reported. Four of these show phylogenetic 
conservation and map within the 3' UTR. They are the 3' -terminal poly[ A] tail 
(Spagnolo et al. , 2000), a long-range stem interaction between nts 65 through 71 
and 124 through 130 from the base of the poly[A] tail in BCoV (nts 68 through 74 
and 136 through 142 in MHV-JHM) (Liu et al. , 2001), a pseudoknotted RNA 
secondary structure consisting of nts 173 through 226 from the base of the 
poly[ A] tail in BCo V (nts 185 through 238 in MHV-A59) (Williams et al. , 1999), 
and a bulged stem-loop RNA secondary structure consisting of nts 222 through 
289 from the base of the poly[A] tail in BCoV (nts 234 through 301 in MHV­
A59) (Hsue et al. , 2000; Hsue et al. , 1997). One cis-acting element for DI RNA 
replication has so far been reported in the 5' UTR and is the 65 nt leader region 
(nts 1 through 65), comprising all of an identified stem-loop I and part of an 
identified stem-loop II (Chang et al. , 1994). Cis-acting replication elements in the 
5' and 3' UTRs in the coronavirus RNA genome and their counterparts in the 
antigenome are proposed to function in genome replication, possibly as sites for 
the binding of the viral polymerase (RNA-dependent RNA polymerase or RdRp) 
and associated proteins in the formation of the replication complex. 
In the research described here, two cis-acting elements for replication of 
BCoV DI RNA, in the 5 '  UTR have been identified. These are stem-loops III (nts 
97 through 116; Chapter II), and IV (nts 186 through 215; Chapter IV). An 
element that probably functions as a replication enhancer has also been identified. 
This is the stem-loop III-associated intra-5' untranslated region open reading 
frame (intra-5' UTR ORF) (Chapter II). 
Proteins found to bind to replication-important cis-acting regions in 
coronavirus RNA. Protein binding studies have demonstrated the binding of 
twenty three cellular proteins to the 5' and 3' untranslated regions of BCo V and 
MHV, another group 2 coronavirus. Of these, four have been identified and are 
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the hnRNP A 1 (heterogeneous nuclear ribonucleoprotein A 1 ), PTB 
(polypyrimidine tract binding protein), Poly[ A] binding protein (P ABP), and 
mitochondrial aconitase (Table 1 . 1  ). Only one viral protein, the N protein has 
been shown to bind to the 5 '  UTR (nts 56 through 72), and the ORF l b  packaging 
signal in MHV, the 3' UTR in IBV, and the 3 '  end of the N ORF (nts 1 44 1  
through 1 875) in BCo V DI RNA pDrep (Table 1 .  1 ). 
In the research described here, stem-loop III (nts 97 through 1 1 6) has been 
proposed to function in replication through its interactions with viral proteins (N 
and an unidentified 22 kDa protein) in the positive strand, and cellular proteins 
(seven proteins between 25 kDa to 76 kDa) in the negative strand (Chapter 111) . 
Stem-loop IV (nts 1 86 through 2 1 5) has been proposed to function in replication 
through its interactions with eight cellular proteins (between 25 kDa to 75 kDa) in 
the positive strand (Chapter IV). 
OBSERVATIONS THAT LED TO THIS RESEARCH 
Previous studies using TGEV (transmissible gastroenteritis coronavirus) 
(Sethna et al. , 1 989) and BCo V (Hofmann et al. , 1 990) had led to the hypothesis 
that coronavirus mRNAs undergo amplification by a replication mechanism. In 
the study done by Sethna et al. , using Northern blot assays, genomic and 
subgenomic length negative strands were found in cells that were infected with 
TGEV. While the genomic length negative strand was the minus-strand full 
length copy of the genome that is synthesized during replication of the genome, 
the subgenomic length negative strands were proposed to be intermediates in the 
replication of sg mRNA (Sethna et al. , 1 989). Subgenomic mRNA length 
negative strands were later found in cells that were infected with BCo V (Hofmann 
et al. , 1 990). This led to the hypothesis that all coronavirus mRNAs might be 
undergoing amplification by a replication mechanism. When testing this 
hypothesis in BCoV, however, it was found that an mRNA, construct pNrep2 (a 
1 1  
Table 1.1. Proteins found to bind to replication-important cis-acting regions in . Ad d fl B . 2001 . h coronav1ruses. apte rom nan, , wit perm1ss1on. 
Protein identity Binding region 
hnRNP Al (35-38 kDa) 3' end of leader (-)\ intergenic sequence nts 70-76(-), 
in MHV (Li et al. , 1997) 
Polypyrimidine tract- 5' end of leader (+)0 in MHV; complementary strand 
binding protein (PTB) of the genome 3' UTR, nt 53-149 (strong) and nt 270-
(55 kDa) 307 (weak) (Huang et al. , 1999; Li et al. , 1999) 
Poly[ A] binding protein 3' poly[ A] tail in MHV and BCo V (Spagnolo et al. , 
(73 kDa) 2000) 
Mitochondrial aconitase nt 1-42 from the 3 '  end ofMHV (Nanda et al. , 2001) 
(90 kDa) 
Proteins of 99, 95, 40- 3' UTR of MHV and BCo V (Spagnolo et al. , 2000) 
50, and 30 kDa 
Proteins of 120, 55, 40, nt 129-166 from the 3' end ofMHV (Yu et al. , 1995) 
and 25 kDa 
Proteins of 142, 120, nt 85-487 from the 3' end ofMHV (Yu et al. , 1995) 
100, 55, and 33 kDa 
Proteins of 120, 103, 81, nt 1-42 from the 3' end of MHV (Yu et al. , 1995) 
70, and 55 kDa 
Viral nucleocapsid (N) 3' end of leader ( +) (Nelson et al. , 2000), and ORF 1 b 
protein (Nelson et al. , 2000) in MHV, 3' end of N ORF in 
BCoV (Cologna et al. , 2000), 3' UTR in IBV (Zhou et 
al. , 1996) 
a. Negative strand (-). 
b. Positive strand ( + ). 
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reporter-containing mRNA 7 that codes for the bovine coronavirus N protein) 
when transfected into helper-virus infected cells, does not replicate (Chang et al., 
1 994) (Fig. 1 .3 A). The difference between pDrepl (the DI RNA that replicates) 
and pNrep2 (the mRNA that does not replicate) is an additional 421 nucleotides in 
pDrepl (Fig. 1 .3 B). This region includes nucleotides 74 through 2 10  of the 5' 
untranslated region and also part (289 nts) of the ORF la  gene. Thus, it was 
thought that these 421 nucleotides might contain cis-acting elements for bovine 
coronavirus DI RNA replication. Also, since previous studies had indicated that 
ORF l a  is translated by ribosomal scanning from the 5' end of the genome 
(Senanayake et al. ,  1 999), it was proposed that putative cis-acting elements for DI 
RNA replication identified within this 42 1 nt region do not function as internal 
ribosomal entry site elements directing an internal entry of ribosomes for the 
translation of ORF 1 a. 
In the research described here two cis-acting replication elements (stem­
loops III and IV), and one replication enhancer element (stem III associated ORF) 
that map within these 421 nts are characterized. 
1 3  
CHAPTER II. STEM-LOOP III JN THE 5' UNTRANSLATED 
REGION IS A C/S-ACTING ELEMENT IN BOVINE 
CORONA VIRUS DI RNA REPLICATION. 
INTRODUCTION 
The 5' and 3 '  untranslated regions (UTR) in the coronavirus RNA 
genome, and their counterparts in the antigenome, are presumed to carry primary 
and higher-order structural elements important for genome replication, possibly as 
sites for the binding of viral RdRp and associated proteins in formation of the 
replication complex. For BCo V, one molecule being used for the identification of 
UTR-mapping cis-acting RNA replication elements is a cloned, naturally­
occurring 2.13 kilobase (kb) DI RNA that undergoes replication in the presence of 
BCo V helper virus (Chang and Brian, 1996; Chang et al. , 1994; Chang et al. , 
1996). The BCoV DI RNA is composed of the fused termini of the virus genome 
(the 5'-terminal 496 nts and the 3 ' -terminal 1637 nts exclusive of the poly[A] tail 
[fused at the third nt upstream of the N start codon] ,  and a poly[A] tail of 68 nts). 
To facilitate quantitation of replication by Northern assays, a 30-nt in-frame 
reporter sequence has been inserted at a unique Bgl II site at position 1093 to 
form construct pDrepl (Chapter I, Fig. 1 .3 A) (Chang et al. , 1 994). To date, with 
the use of this and DI RNA molecules from the mouse hepatitis �oronavirus 
(MHV), another group 2 coronavirus, five putative UTR-mapping, cis-acting 
replication elements have been experimentally identified. Four of these show 
phylogenetic conservation and map within the 3 '  UTR. They include the 3 ' -
terminal poly[ A] tail (Spagnolo et al. , 2000), a long-range stem interaction 
between nts 65 through 71 and 124 through 130 from the base of the poly[A] tail 
in BCoV (nts 68 through 74 and 136 through 142 in MHV-JHM) (Liu et al. , 
2001), a hairpin-type pseudoknot consisting of nts 173 through 226 in BCoV (nts 
185 through 238 in MHV-A59) (Williams et al. , 1999), and a 5' -proximal 
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extended bulged stem-loop consisting of nts 222 through 289 in BCoV (nts 234 
through 301 in MHV-A59) mapping immediately downstream of the N gene stop 
codon and overlapping the pseudoknot by five nucleotides (nts) (Hsue et al. , 
2000; Hsue et al. , 1997). The importance of the 5' -proximal intra-3' UTR bulged 
stem-loop in RNA replication has been confirmed in the context of the intact 
MHV genome (Hsue et al. , 2000). Within BCo V DI RNA, the 65-nt leader, 
comprising all of an identified stem-loop I and part of an identified stem-loop II, 
has been shown to function in DI RNA replication (Chang et al. , 1994). The 
identity of 5' and 3' UTR-mapping cis-acting elements is consistent with results 
of deletion analyses showing dependence of DI RNA replication on coronavirus 
terminal sequences (Chang et al. , 1994; Dalton et al. , 2001; Izeta et al. , 1999; 
Kim et al. , 1993; Lin et al. , 1994 ). 
Here, we extend our earlier observations on a potential 5' UTR-mapping 
stem-loop III (Chang et al. , 1996) and examine its function in DI RNA 
replication. We describe its phylogenetic conservation among group 2 
coronaviruses, compare its properties with a potential homolog in coronavirus 
groups 1 and 3, test its existence in BCoV RNA by further enzyme structure 
probing, document by mutation analyses the requirement of the stem for 
replication, and identify a potentially important role for the associated intra-5' 
UTR ORF in the replication of BCo V DI RNA. 
MATERIALS AND METHODS 
Virus and Cells. A DI RNA-free stock of the Mebus strain of BCoV at 4.5 
X 108 PFU/ml was prepared and used as a helper virus as previously described 
(Chang and Brian, 1996; Chang et al. , 1994; Chang et al. , 1996; Williams et al. , 
1999). The human rectal tumor cell line HRT-18 (Tompkins et al. , 1974) was 
used as previously described (Chang and Brian, 1996; Chang et al. , 1994; Chang 
et al. , 1996; Hofmann et al. , 1991; Hofmann, Chang et al. , 1993; Hofmann et al. , 
1993; Hofmann et al. , 1990; Ozdarendeli et al. , 2001; Williams et al. , 1999). 
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Plasmid constructs. Construction of pGEM3Zf(-) (Promega)-based pDrep 
1 has been previously described (Chang et al. , 1 994). To construct the plasmid 
derivatives of pDrep 1 ,  overlap PCR mutagenesis (Horton et al. , 1 990) was done 
using oligonucleotides listed in Table 2. 1 .  The strategy used for constructing each 
of the derivatives was the same as that for pSLIII-mutlR except for the 
differences noted. For making pSLIII-mutlR, Nde l (+), SL3R(-), and pDrep l 
DNA were used in the first PCR, Hpal (+), GEM3Zf(-)Nde l (-), and pDrep l DNA 
were used in the second reaction, and GEM3 Zf(-)N de 1 (-) and Nde 1 ( +) and the 
products of the first two reactions were used in the third reaction to make a 1 1 83-
nt product that was trimmed to 693 nts with restriction endonucleases NgoM IV 
and A vr II and cloned into N goM IV/ A vr II-linearized pDrep 1. For making 
pSLIII-mut lL, SL3L(-) replaced SL3R(-) in the first reaction. For making 
pSLIII-mutl L/R, SL3L(-) replaced SL3R(-) and pSLIII-mutlR DNA replaced 
pDrep l DNA in the first reaction and pSLIII-mutlR DNA replaced pDrep l DNA 
in the second reaction. For making pSLIII-mut2L, SRST3L(-) replaced SL3R(-) 
in the first reaction and SRST3L(+) replaced Hpal (+) in the second reaction. For 
making pSLIII-mut2R, SRST3R(-) replaced SL3R(-) in the first reaction and 
SRST3R(+) replaced Hpal (+) in the second reaction. For making pSLIII­
mut2L/R, SRST3double(-) replaced SL3R(-) and pSLIII-2R DNA replaced 
pDrep l DNA in the first reaction, and SRST3double(+) replaced Hpal (+) and 
pSLIII-mut2R DNA replaced pDrep l DNA in the second reaction. For making 
pSLIII-mutG 109➔ A, SRG 109T(-) replaced SL3R(-) in the first reaction and 
SRG109T(+) replaced Hpal (+) in the second reaction. For making pSLIII­
mutGl lO➔A, SRGl l OT(-) replaced SL3R (-) in the first reaction and 
SRGl lOT(+) replaced Hpal (+) in the second reaction. For making pSLIII-mut5, 
SRAU99(-) replaced SL3R(-) in the first reaction, and SRAU99( +) replaced 
Hpal (+) in the second reaction. For making pSLIII-mut6, SR8 1 (-) replaced 
SL3R(-) in the first reaction, and SR8 1 (+) replaced Hpal (+) in the second 
reaction. For making pSLIII-mut3L, SRTlOlC(-) replaced SL3R(-) in the first 
reaction, and SRT101 C(+) replaced Hpal (+) in the second reaction. For making 
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Table 2.1. or leotid d in chaoter II 
Oligonucleotide1 Polarity Sequence (5'->3')° Binding 
region in 
pDrepl 
GEM3Zf(-) + GAGAGTGCACCATATGCGGTGT 2498-25 1 9c 
Ndel(-) 
Hpal(+) - GGCTGAAAGCTGTTAACAGCAGAAATG 140-166 
Ndel(+) - CCTCCAAATCATATGGACGTGTATTC 456-481 
SL3L(-) + CCACTCCCTGTATTgmgGCTTGTGGGC 84-111 
SL3R(-) + GCTTGTGGGCtatcATTTTTCA T AGTGG 102-129 
SR81(-) + CATCCACTCCCTGTATagaATGCTTGTGGGaGTAGATTTTTCATAGTGG 81-129 
SR81(+) - CCACT ATGAAAAA TCT ACtCCCACAAGCA TtctA T ACA TTT AGTGGA TG 81-129 
SRAU99(-) + CATCCACTCCCTGTATTCaATGCTTGTGGGCGTtGATTTTTCATAGTGG 81-129 
SRAU99(+) - CCACTATGAAAAATCaACGCCCACAAGCATtGAATACAGGGAGTGGATG 81-129 
SRDM(+) - GTTGATCTTCGACATTGTGACC 204-225 
SRG109T(-) + CTATGCTTGTGtGCGTAGATTTTTCATAG 98-126 
SRG109T(+) - CTATGAAAAATCTACGCaCACAAGCATAG 98-126 
SRGl lOT(-) + CTATGCTTGTGGtCGTAGATTTTTCATAG 98-126 
SRGll0T(+) - CTATGAAAAATCTACGaCCACAAGCATAG 98-126 
SRleader(-) + GATTGTGAGCGATTTGCGTGCGTGC 1-25 
SRST3double(-) + CACTCCCTGTATagaATGggTGTGtcCGTtct 85-116 
SRST3double( +) - agaACGgaCACAccCA TtctA T ACAGGGAGTG 85-116 
SRST3L(-) + CACTCCCTGTATagaATGggTGTGGGCGTAGA 85-116 
SRST3L(+) - TCT ACGCCCACAccCA TtctA T ACAGGGAGTG 85-116 
SRST3R(-) + GTATTCT A TGCTTGTGtcCGTtctTTTTTCA T AGTGG 93-129 
SRST3R(+) - CCACT ATGAAAAAagaACGgaCACAAGCAT AGAA TAC 93-129 
SRT101C(-) + CCACTCCCTGTATTCTAcGCTTGTGGGCG 84-112 
...... 
00 
Table 2.1. Continued. 
Oligonucleotide8 Polarity Sequence (5'->3')b Binding region in 
pDrepl 
SRT101C(+) - CGCCCACAAGCgTAGAATACAGGGAGTGG 84-112 
SRUTRSTOP(-) + CCACTCCCTGT ATTCTtaGCTTGTGGGCtaAGATTTTTCATAGTG 84-128 
SRUTRSTOP( +) - CACTATGAAAAATCTtaGCCCACAAGCtaAGAATACAGGGAGTGG 84-128 
TGEV8(+) - CATGGCACCATCCTTGGCAACCCAGA 1098-1123 
TGEV8b(+) - CATGGCACCATCCTTGGCA 1105-1123 
a. The positive and negative symbols in the oligonucleotide names indicate the polarity of the nucleic acid to which the 
oligonucleotide anneals . 
b. Lowercase bases represent mutated sites. 
c. Indicates nucleotide positions in the pGEM3Zf(-) vector. 
pSLIIl-mut4L/R, SRUTRSTOP(-) replaced SL3R(-) in the first reaction, and 
SRUTRSTOP(+) replaced Hpa l (+) in the second reaction. 
Enzyme structure probing of RNA. Enzyme structure probing of RNA 
was carried out as previously described (Ozdarendeli et al. , 2001). Briefly, for in 
vitro synthesis of RNA, 10 ug of Xba I-linearized mung bean nuclease-blunt­
ended pDrep I DNA in a 200 ul reaction volume was transcribed at 37° C for I h 
using 80 U of T7 RNA polymerase (Promega) to yield approximately 40 ug of a 
595-nt long vector-free transcript. RNA was treated with 10 U of RNase-free 
DNase (Promega) at 37° C for 30 min, extracted with phenol/chloroform and 
chloroform, chromatographed through a Biospin 6 column (Bio-Rad), 
spectrophotometrically quantitated and stored in water at -20° C. For RNase 
treatments, 40 ug of RNA was heat denatured at 65°C for 3 min, renatured by 
slow cooling (0.5 h) to 35°C in a 400 ul reaction volume containing 30 mM Tris 
HCl (pH 7.5)-20 mM MgCh-300 mM KCl, and aliquots containing 2 ug of 
sample RNA and 5 ug of yeast tRNA were incubated in 100 ul of the same buffer 
and 0.05, 0.5, 1, 2, or 4 U of RNase CVI (Pharmacia), 0.05, 0.5, 1, 5, or 10 U of 
RNase T l  (GIBCO), 0.05, 1, 2, 3, or 4 U ofRNase T2 (GIBCO). RNase 
digestion was carried out at 25° C for 15 min and terminated by the addition of 
150 ul of 0.5 M sodium acetate after which the RNA was extracted with 
phenol/chloroform, chloroform, and ethanol precipitated. Digested RNA 
preparations were used in primer extension reactions with 5 '  -end-labeled plus 
strand-binding oligonucleotide SRDM(+) (Fig. 2. 1 ). Undigested RNA was used 
with the same primer in dideoxynucleotidyl sequencing reactions to generate a 
sequence marker. Products were analyzed on a DNA sequencing gel of 6% 
polyacrylamide. 
Northern assay for DI RNA replication. The Northern assay was 
performed essentially as previously described (Chang and Brian, 1996; Chang et 
al. , 1994; Chang et al. , 1996; Hofmann et al. , 1990; Williams et al. , 1999). 
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Fig. 2 . 1 .  Phylogenetic and enzyme structure probing evidence for stem-loop III. 
A. Predicted secondary structures within the first 1 26 nts of the 2 1 0-nt 5' UTR of 
the BCo V genome and the site from which 5' end-labeled primer was extended 
for stem-loop III structure determination. The 65-nt BCoV leader sequence is 
shaded and the leader-associated UCUAAAC intergenic sequence (nts 64-70) 
found within loop II is identified in bold. The start and stop codons for the intra-
5' UTR ORF and the start codon for ORF la  are boxed. Previously described 
stem-loops I and II are identified. Stem-loop III is shown along with the variant 
bases found among the eight sequenced members of group 2 coronaviruses. 
Bases named with no superscript are found in all MHV strains (A59, 2, JHM); 
superscript identity: 2, MHV-2; a, MHV-A59; j, MHV-JHM; he, human enteric 
CoV-4408; e, equine coronavirus. Stem-loop III is identical in BCoV, HEV, and 
HCo V-OC43. B. Enzyme probing data for stem-loop III. Depicted is a DNA 
sequencing gel showing separation of primer extension products. RNase 
digestion conditions for the single strand-digesting RNase T2 and double strand­
digesting RNase CVl are described in the text. Lanes 5-8 show the products of 
an RNA sequencing reaction done on undigested RNA to identify the base 
positions. C. Summary of enzyme probing data shown in part B. 
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Briefly, cells at 80% confluency (~1Xl06 cells per dish) in 35 mm diameter 
dishes were infected with BCo V at a multiplicity of 10 PFU per cell and 
transfected with 500 ng of DI RNA transcript in Lipofectin (Invitrogen) at 1 hpi. 
For passage of progeny virus, supernatant fluids were harvested at 48 hpi and 500 
ul were used to infect freshly confluent cells in a 35-mm dish. RNA was 
harvested at the designated times and at 48 h after virus passages (VP) 1 and 2. 
Total RNA extracted by the NP-40-proteinase K method (yielding approximately 
10 ug per dish) was stored as an ethanol precipitate and precisely one fourth of the 
preparation was used per lane for formaldehyde-agarose gel electrophoresis. 
Approximately 1 ng of transcript was loaded per lane as a size marker. Northern 
blots were probed with reporter-specific oligonucleotide TGEV 8( +) 5'-end 
labeled with 32P to specific activities of 1.5 X 105 to 3 .5 X 105 cpm/pmol 
(Cerenkov counts). Blots were read with a Packard Instant Imager 
Autoradiography System for quantitation and exposed to Kodak XAR-5 film for 6 
h to 5 days at -80°C for imaging. Images were recorded by digital scanning of the 
film. In every experiment in which the replication of mutants of pDrep 1 RNA 
were examined, wt pDrep 1 RN A was examined in parallel. 
Sequence analysis of the stem-loop III region in progeny DI RNAs. For 
direct sequencing of asymmetrically-amplified cDNA, the procedure as described 
by Hofmann et al (Hofmann et al. , 1993) for analysis of plus-strand RNA was 
used. For this, oligonucleotides TGEV8b(+) and SRleader(-) were used for RT­
PCR with RNA extracted at 48 hpi from cells infected with the first passage virus 
(VPl), and in some cases second passage virus (VP2), and 5'end-radiolabeled 
oligonucleotide SRDM(+), Hpal(+), or SRleader(-) was used for sequencing. 
When mixed sequences were revealed by this method, R T-PCR fragments were 
cloned with the TOPO XL PCR cloning kit (Invitrogen) and sequenced. 
Synthetic oligonucleotides and accession numbers. Oligonucleotides used 
in this study are described in Table 2.1 and GenBank accession numbers for the 
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sequences studied are M62375 , M1 6620, and M306 12  for BCoV-Mebus, 
AF523843 for HCoV-OC43 , AF523844 for HECoV-4408, AF523845 for HEV-
67N, AF523846 for ECoV-NC99, NC00 1 846 for MHV-2, M27 198 for MHV­
A59, M55 148 for MHV-JHM, 234093 for TGEV-Purdue 1 1 6, 6972 1 for HCoV-
229E, and M42 for IBV-Beaudette. 
RESULTS 
A predicted stem-loop III with an associated short ORF in the BCoV 5 '  
UTR shows phylogenetic conservation among group 2 coronaviruses. Earlier 
studies (Bouma, 1 997) using the Tinoco algorithm (Tinoco et al. , 1 973) had 
predicted a potential stem-loop III with a helix of seven base pairs and a loop of 
six nts mapping at nts 97 through 1 1 6 in the 2 10-nt 5 '  UTR of BCoV although 
enzyme structure probing had indicated the stem was probably eight base pairs 
and the loop 4 nts in length (Chang et al. , 1 996). An AUG start codon for an 
intra-5 '  UTR ORF of24 nts was found within the stem beginning at base 1 00. In 
the same study, stem-loops I and II were identified as components of a required 
5 '-terminal cis-acting element for BCo V DI RNA replication. Structure 
predictions, however, have failed to show a consistent pattern for stem-loops I and 
II among the group 2 coronaviruses (Chang et al. , 1 996; and data not shown) 
suggesting that perhaps a specific sequence rather than higher-order structures in 
the 5 '-terminal leader region is important for this cis-acting function. 
To further evaluate the higher-order nature of stem-loop III in BCo V, in 
the present study, the genomic 5 '  -terminal sequences were analyzed by the mfold 
program of Zuker (http://bioinfo.math.rpi.edu/,--zukerm/; Mathews et al. , 1 999; 
Zuker et al. , 1 999) and a stem-loop with a stem of eight base pairs, a loop of four 
nts, and a free energy value of -9. 1 kcal/mole was predicted (Fig. 2. 1 A). In the 
minus strand, a stem-loop with an internal loop, a terminal hexaloop, and a free 
energy of -3 .0 kcal/mole was also predicted (Fig. 2.2). The UGUG loop in the 
positive strand does not belong to any identified family of especially stable 
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Fig. 2.2. Integrity of stem III is required for DI RNA replication as determined by 
analysis of mutant 1 variants of pDrep 1 .  The mfold-predicted structures of wt and 
mutant transcripts of pDrepl (pSLIII-mutlL, pSLIII-mutlR, and pSLIII­
mutlL/R) in the positive and negative strands, and their calculated free energies 
in kcal/mole, are shown. The start codon for the intra-5' UTR ORF is boxed 
(note that this moves 1 base position upstream in pSLIII-mutlL and pSLIII­
mutlL/R relative to wt). Mutated bases are shown as lowercase letters. For 
Northern analyses, T7 RNA polymerase-generated transcripts of linearized 
plasmids were transfected into BCo V-infected cells and RNA was extracted at the 
indicated times posttransfection and probed with a reporter-specific radiolabeled 
oligonucleotide. Accumulation of mutant molecules was determined by 
quantitative blotting of RNA harvested at the times indicated and at 48 h 
postinfection with virus passage 1. Accumulation of pDrep 1 progeny was 
considered to be 1 00%. The sequence of the RNA in the progeny replicons was 
determined by either bulk R T-PCR sequencing using pDrep I -specific primers as 
described in the text, or by first cloning and then sequencing of plasmid DNA 
from isolated colonies. Lanes: Uninf., mock infected, non-transfected cells; Inf., 
infected, non-transfected cells; RNA, sample of the transcript. 
1MACGRRFFIVVSIFISA VNSFQPGTCCILGSGPPIGHNVEDQQIRSR TTLGS 
RISMDV. 2Identical to the amino acid sequence predicted for mutant pSLIII-L 
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tetraloops (UNCG, GNRA, CUNG) (V arani, 1995) suggesting it may not 
contribute extraordinarily to stem-loop stability. 
5 '  UTR sequences for 1 2  coronaviruses have now been reported enabling 
comparisons of predicted higher-order structures ( see references associated with 
GenBank accession numbers). For the eight members in group 2, BCo V -Mebus, 
HCoV-OC43, HECoV-4408, HEV-67N, ECoV-NC99, MHV-2, MHV-A59, and 
MHV-JHM, an mfold-predicted stem-loop III with small variations was found 
(stem-loop III is identical in BCoV, HCoV-OC43 and HEV) (Fig. 2 . 1 A) (Table 
2.2). That is, there was predicted (i) a stem-loop III in the positive strand with a 
stem ( with or without an internal loop) of seven or eight nts, a terminal tetraloop, 
and a net negative free energy within the range of - 1 1 .5 to -5 . 1  kcal/mole, (ii) a 
stem-loop in the negative strand with a net negative free energy within the range 
of -9.3 to -3.0 kcal/mole, and (iii) an AUG start codon for an ORF of 24 nts 
beginning at the third or fourth base position in the stem of the positive strand. 
The stem begins at base 96 for ECoV, 97 for MHV-A59 and MHV-2, and 10 1  for 
MHV-JHM, and an internal loop occurs at the fourth base position in the stem for 
all MHV strains and at the fifth base in ECo V. Although there is no evidence for 
a conserved primary sequence among coronavirus groups 1 -3 in the region of 
stem-loop III, mfold analyses of groups 1 and 3 revealed a possible stem-loop III 
homolog in the same relative position within the 5 '  UTR (see Discussion). 
Interestingly, all possess a closely-associated AUG start codon for a short intra-5 ' 
UTR ORF (Table 2.2). Thus, from folding predictions and evidence of 
phylogenetic conservation it was postulated that stem-loop III in BCoV DI RNA 
is a higher-order structure with possible function in RNA replication. 
Enzyme structure probing supports the existence of stem-loop III in BCo V 
RNA. Previous enzyme structure probing of the 5 '-terminal 262-nt region of the 
BCoV genome had revealed, along with stem-loops I (nts 1 1  through 42) and II 
(nts 5 1  through 84), a stem-loop III with an 8-base stem and a tetraloop (Chang et 
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a. As determined by the Zuker algorithm. 
Kozak context Predicted Amino acid sequence 
of the short number of amino of short ORF product 
ORF start acids encoded by 
codon short ORF 
UCUaugC 8 MLVGVDFS 
UCUaugC 8 MLVGVDFS 
UCUaugC 8 MPVGVDFS 
UCUaugC 8 MLVGVDFS 
UCUaugC 8 MLASLDFS 
UCCaugC 8 MPAGLVLS 
UCCaugC 8 MPVGLVLS 
UCCaugC 8 MPVGLVLS 
UCUaugA 3 MKS 
GCUaugG l l c MAGIFDAGVVVC 
UGGaugG 1 1  MAPGHLSGFCY 
b. For TGEV, HCoV-229E and IBV, the Zuker algorithm predicts a larger stem-loop than for the group 2 coronaviruses. 
c. A second ORF beginning 16  nt downstream from the first encodes the amino acid sequence MLES. 
flanking sequences, evidence for stem-loop III was reexamined in the context of a 
595-nt transcript, in the present study. For this, 5 ' -terminal transcripts of Xba I­
linearized pDrepl DNA were made and subjected to digestion with either single 
strand-specific RNases Tl  (data not shown) or T2, or with double strand-specific 
RNase CVl, and the products were analyzed by reverse transcriptase extensions 
of 5 '  end-labeled primer SRDM(+) (Fig. 2. 1 B, lanes 1 -4 and 9- 13). Radiolabeled 
products of an RNA sequencing reaction were analyzed in parallel to determine 
sites of RNase digestion (Fig. 2. 1 B, lanes 5-8). The results show single- and 
double-stranded regions in agreement with an mfo/d-predicted structure (Fig. 2. 1 
C). 
Integrity of stem III is required for BCo V DI RNA replication. To 
examine the importance of the helical region in stem-loop III for DI RNA 
replication, site-directed mutations in pDrep 1 predicted to disrupt and then restore 
base-pairing with compensatory changes were made and transcripts were tested 
for replication. A stem was deemed required for replication if helix-disrupting 
mutations led to loss of accumulation ( as determined by the absence of mutant 
progeny molecules in VPl RNA) and structure-restoring compensatory mutations 
led to some level of restored accumulation ( as determined by the presence of the 
double mutant progeny in VPl RNA). Analyses focused on DI RNA progeny in 
VP I since (i) passaged (i .e., packaged) molecules should be free of long-lived 
transfected mutant transcripts that would otherwise appear as progeny in RT-PCR 
assays, and (ii) Northern assays alone do not discriminate between replicating 
mutant and replicating (recombination-derived revertant) wt molecules. 
In earlier studies, a set of mutants, pSLIII-mutlL and pSLIII-mutlR were 
made in which four of the eight base-pairs were disrupted in each the left and 
right arms, and a double mutant pSLIII-mut 1 L/R in which stem III is restored was 
made, and replication of these mutants was studied using Northern assays 
(Bouma, 1 997). 
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In the present study, the replication assay of mutants pSLIII-mut lL, 
pSLIII-mutlR, and pSLIII-mutlL/R was repeated. Mutants pSLIII-mut lL  and 
pSLIII-mut lR had stem-loop III free energy values of -2.2 and - 1 .7 kcal/mole in 
the positive strands, respectively, and no predicted structures in the negative 
strands (Fig. 2 .2). By Northern analysis of mutants pSLIII-mut lL  and pSLIII­
mut lR, 6% or less ofwt levels of RNA had accumulated by 24, and <1 % 48 hpt 
and by 48 hpi in VPl .  Sequence analysis of asymmetrically amplified cDNA 
from VPI RNA showed the products of both mutants pSLIII-mut lL  and pSLIII­
mut lR  to be revertants to wt and thus the mutants had not replicated. By contrast, 
accumulation of progeny from double mutant pSLIII-mutlL/R for which the free 
energy value had become -8.8 kcal/mole in the positive strand and -3 .0 kcal/mole 
in the negative strand was 14% of wt levels in VP 1 ,  and asymmetrically-amplified 
cDNA from progeny molecules in VP I ,  as well as in cDNA clones of these, 
showed progeny to be a mixture of wt and double mutant sequences (Fig. 2.2). Of 
8 clones sequenced, 2 were wt and 6 were the SLIII-mutlL/R mutant. cDNA 
from VP2 also showed a mixture of wt and mutant sequences indicating continued 
replication of the double mutant through a second virus passage. These results 
together indicate that the helical region of stem-loop III either in the positive or 
negative strand or both is a requirement for DI RNA replication. A lower rate of 
accumulation in the double mutant than in wt, however, suggested that factors 
other than the helical nature of the stem, perhaps the stability of the stem, the 
nucleotide sequence within the stem, the size and location of the stem-loop­
associated ORF, or the ORF product, might also be important for maximal 
accumulation. 
To test for the requirement of the stem under conditions that would 
minimally disrupt the short ORF, a second set of three mutants was examined in 
which the short ORF product differed from wt by no more than three amino acids 
(Fig. 2 .3). In pSLIII-mut2L, five of the eight bases in the left arm were changed 
leaving only those in the wt l 00AUG codon unchanged and increasing the free 
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nt seq. short ORF 
in VP1 product 
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all wt MLVS.VlFS 
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Fig. 2.3 .  Integrity of stem III is required for DI RNA 
replication as determined by analysis of mutant 2 variants of 
pDrepl .  The assays were carried out as described in Fig. 2.2 
except that mutant variants (pSLIII-mut2L, pSLIII-mut2R, 
and pSLIII-2L/R) were used. 
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structure in the negative strand. The changes altered only the second amino acid 
(L ➔ G) yielding a potential oligopeptide product of MGVGVDFS. In pSLIII­
mut2R, five nucleotides in the right arm were changed maintaining the 1 1 1  CGU 
base-pairing partner with l 00AUG, increasing the free energy in the positive 
strand to +2.3 kcal/mole and leading to no predicted structure in the negative 
strand, and potentially encoding an oligopeptide product of ML V.S.VLFS.  In the 
double mutant pSLIII-mut2L/R, the calculated stem-loop III free energy was 
- 1 0.0 kcal/mole in the positive-strand, -3 .2 kcal/mole in the negative-strand, and 
the potential ORF product, MGV.SVLFS. Northern analyses of progeny from 
pSLIII-mut2L and pSLIIl-mut2R showed an accumulation of <1  % of wt levels at 
24 and 48 hpt and in VP 1 ,  and sequence analyses of asymmetrically-amplified 
cDNAs showed progeny to be all revertant wt molecules indicating the mutants 
had not replicated. On the other hand, accumulation of progeny from the double 
mutant pSLIII-mut2L/R was > 26% of wt levels at 24 and 48 hpt and > 2% in VP 1 ,  
and all progeny in VP 1 had retained the mutant sequences. Thus, these results are 
consistent with the experiment described in Fig. 2.2 and suggest that stem-loop III 
either in the positive or negative strand, or both, is required for replication. A less 
than wt level of accumulation for the double mutant, however, would suggest 
again that perhaps the nt sequence within the stem or possibly the amino acid 
sequence of the short ORF product were not optimal for maximal accumulation. 
The notion that the nt sequence within the stem or the amino acid 
sequence of the ORF product are important factors in accumulation in the context 
of an otherwise stable stem was supported by results from mutants in which single 
base changes were made in the upper part of the stem. In mutant pSLIII-
mutG 1 09➔ A a stem of 8 nts was predicted for which the free energy of stem­
loop III became -9.0 kcal/mole in the positive strand, --4.2 kcal/mole in the 
negative strand, and the potential ORF product became ML V.SVDFS, and in 
pSLIII-mutG 1 1  o➔ A a stem of 7 nts was predicted for which the free energy of 
stem-loop III became -4. 1 kcal/mole in the positive strand, - 1 .0 in the negative 
strand, and the potential ORF product became ML VDVDFS (Fig. 2 .4 A and B). 
3 1  
Fig. 2.4. Importance of stem III for DI RNA replication independent of the 
potential short ORF product. The importance of stem III in the presence of little 
(A and B) or no (C) change in the potential short ORF product was measured by 
assays described in Fig. 2.2. A. Accumulation and sequence of progeny from wt, 
or mutant transcripts bearing a mutation at base 1 09 (pSLIII-mutG 109➔ A). B. 
Accumulation and sequence of progeny from wt, or mutant transcripts bearing a 
mutation at base 1 1 0 (pSLIIO-mutG 1 1  o➔ A). C. Accumulation and sequence of 
progeny of wt, or mutants with changes at codon wobble positions that maintain 
the wt ORF product ML VGVDFS. Stem III was maintained in pSLIII-mut5 but 
disrupted in transcripts of pSLIII-mut6. Assays were carried out as described in 
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For these, although only mutant sequences were found in VPl DI RNA, 
accumulation was still less than maximal in that only 4 7 and 9 % of wt levels, 
respectively, were found in VPl .  Thus, to evaluate the role of stem-loop III 
integrity in mutants that contained nt changes but still produced a potential wt 
short ORF product, double mutants were made by changing bases in codon 
wobble positions such that a wt ORF product was retained but that the stem was 
either maintained or disrupted. For these, pSLIII-mut5 was made in which stem 
III was maintained in both the positive (-8.7 1 kcal/mole) and negative (-2.6 
kcal/mole) strands, and pSLIII-mut6 was made in which no structure was 
predicted in either strand of stem-loop III (Fig. 2.4 C). Accumulation of pSLIII­
mut5 progeny was no less than that of wt DI RNA at all time points and the 
sequence of VP 1 progeny were all mutant molecules indicating the stable stem 
mutants potentially producing a wt ORF product replicated at least as well as wt 
stem-loop III. On the other hand, accumulation of pSLIII-mut6 in which no stem­
loop III structure was predicted was at less than wt levels and only 1 5% of wt 
levels were produced in VP 1 for which all progeny had wt sequence. These 
results together demonstrate that the integrity of stem-loop III is important for 
replication independent of any effect of the short ORF product, and that at least 
some nucleotide changes in the stem are well tolerated. 
Replication ofBCoV DI RNA shows a strong preference for the presence 
of a stem-loop III-associated short ORF. An association of an AUG-initiated 
short ORF with stem-loop III (or its presumed homolog) in all coronaviruses (see 
Discussion) led us to hypothesize that the short ORF plays a role as a cis-acting 
element in replication. To test whether it does, the DI RNA was modified in ways 
that were predicted to either diminish or prevent translation of the ORF but 
minimally perturb the integrity of stem-loop III. In the first modification, pSLIII­
mut3L was made in which l00AUG was changed to l00AcG, a threonine codon 
known to function inefficiently as a translation start codon (Peabody, 1 989) (Fig. 
2.5 A). In this construct it was predicted by mfold that base-pairing in the positive 
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Fig. 2.5. A stem-loop III-associated short ORF correlates with 
maximal DI RNA accumulation. A. Accumulation and 
sequence of progeny from DI RNA in which the stem-loop III­
associated short ORF begins with an AcG threonine codon 
(pSLIII-mut3L). The sequence of progeny in VP l was 
determined to be a mixture by sequencing the asymmetrically 
amplified R T-PCR product. B. Accumulation and sequence of 
mutant transcripts in which the stem-loop III-associated short 
ORF begins with a uaG stop codon (pSLIII-4L/R). The 
sequence of progeny molecules in VP 1 was determined from 
clones of the R T-PCR product. Assays were carried out as 
described in Fig. 2.2. 
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strand would be maintained between the AcG codon and the cognate wt triplet 
111 CGU, and that the negative free energy of stem-loop III would increase to 
-10.9 kcal/mole in the positive strand and increase approximately three-fold to 
-9.6 kcal/mole in the negative strand. By Northern analysis, accumulation of 
transcripts in VPl was 18% of wt, and the sequence of the replicating progeny in 
VPl was a mixture of both wt and mutant indicating that some of these mutants 
had replicated. Progeny in VP2 were all wt. These results indicated that 
transcripts with an AcG-initiated short ORF can be replicated but with less 
efficiency than wt DI RNA and that an AUG-initiated ORF is preferred. 
To test the importance of the short ORF by another approach, pSLIII­
mut4L/R was made in which the l00AUG was changed to a l00uaG stop codon 
and its cognate base-pairing triplet was changed from 111 CGU to 111 Cua to 
maintain full base pairing in the stem (Fig. 2.5 B). In pSLIII-mut4L/R, the mfo/d­
predicted stem-loop III had a free energy of -9.3 kcal/mole in the positive strand, 
-7.4 kcal/mole in the negative strand, and no predicted ORF product. Whereas 
Northern analysis showed an accumulation of <1 % of wt after VPl ,  sequence 
analysis of asymmetrically-amplified cDNA of progeny at VPl revealed a 
mixture of l O0A(U,a)G and 111 C(G,u)(U,a). Thus, the cDNA products were 
cloned and sequenced to resolve the makeup of progeny molecules. Of 13 clones, 
5 were wt sequence, 3 showed l00AUG but with a cognate base-pairing 11 lCGa 
triplet (potentially encoding the peptide ML VG1;DFS), and 5 showed 1 00AaG 
(known not to function as a start codon [Peabody, 1989]) with a cognate 111 CGa 
triplet. No clones had the sequence of the original mutations of 1 00uaG or 
111 Cua. All progeny in VP2 were wt as determined from sequencing 
asymmetrically-amplified cDNA. These results, therefore, established that 
molecules with the non-start codon AaG had replicated poorly and those with a 
uaG non-start codon had not replicated indicating, as did the experimental results 
with mutant pSLIII-mut3L (Fig. 2.5 A), that there is a preference by the DI RNA 
for a l 00AUG-initiated short ORF in replicating molecules. 
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DISCUSSION 
In this study, we present evidence that supports the existence of a 
predicted stem-loop III mapping at nts 97 through 116 in the 210-nt long 5' UTR 
of the BCo V genome and show through mutagenesis analyses that the stem of this 
structure is required for the replication of BCoV DI RNA. Stem-loop III has an 
associated AUG that begins an intra-5' UTR ORF of 24 nts, and mutagenesis 
studies of this suggested its maintenance is preferred by the DI RNA for 
replication. The short ORF or its product, therefore, may act to enhance 
replication. Comparison of 5' UTR sequences of eight group 2 coronaviruses 
revealed that stem-loop III and the associated ORF are largely conserved in 
position and structure. Is a stem-loop III also found in the other coronavirus 
groups? Mfold analyses of the 5' UTR sequences of the group 1 coronaviruses 
HCo V-229£ and TGEV (for recently sequenced group 1 coronavirus PEDV see 
Appendix), and the group 3 coronavirus IBV, indicated that a bulged stem-loop 
III analog, if not homo log, of approximately twice the size with an associated 
intra-5'UTR ORF is positioned similarly within the 5' UTR (Fig. 2.6). (For 
recently sequenced HCoV-SARS see Appendix). Except for HCoV-229E, the 
predicted loop is also a tetraloop (in HCo V-229£ it is a three base loop) and in all 
cases the AUG codon for the associated intra-5' UTR ORF is within the stem 
(Fig. 2.6, Table 2.2). ORF-encoded oligopeptides range from 3 amino acids (aa) 
in length in TGEV to 11 aa in IBV and appear to be dissimilar in sequence (Table 
2.2). 
From experiments described here it was not established how stem-loop III 
or the ORF function mechanistically in DI RNA replication. However, several 
questions approaching mechanism are raised. (i) Does stem-loop III function in 
the positive or negative strand, or both? Since base-pair covariations among 
group 2 members maintain stem-loop III in the negative strand (free energy range, 
-9.3 to -3.0 kcal/mole) as well as positive strand (-11.5 to -5.1 kcal/mole) (Table 
2.2), the possibility exists that stem-loop III functions in either strand, or both. 
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The question was not answered by our experiments since net negative free energy 
values were maintained in both the negative- (-4.2 to - 1 .0 kcal/mole) and positive­
(- 1 0.9 to -4. 1  kcal/mole) strand stem-loop III structures in all mutants that 
replicated. (ii) What trans-acting factors, if any, bind stem-loop III? Precedents 
in other plus-strand RNA viruses (Barton et al. , 200 1 ;  Frolov et al. , 200 1 ;  
Gamarnik et al. , 1 998; Herold et al. , 200 1 ;  Teterina et al. , 200 1 ;  and references 
therein) lead us to speculate that stem-loop III most likely binds viral or cellular 
protein(s) in the positive-strand. This would be consistent with studies showing 
translation of an ORF attached to the genomic 5 '  UTR of BCoV to be regulated 
differently in infected and uninfected cells (Senanayake et al. , 1 999). However, a 
cellular protein of 55 kDa has been found to bind to nts 56 through 1 1 2 in the 
MHV-JHM 5'  genome terminus, and cellular proteins of 35 and 38  kDa to bind to 
the minus-strand counterpart of this sequence (Furuya et al. , 1 993 ). Since this 
sequence represents the upstream half of stem-loop III, these proteins become 
candidates for playing a role in stem-loop III function. Preliminary experiments 
in our laboratory have indicated that viral and cellular proteins bind the positive­
strand form of stem-loop III whereas only cellular proteins bind the negative­
strand form (S. Raman and D. Brian, unpublished; Chapter III). Thus the 
interactions of stem-loop III with trans-acting elements of either protein or RNA 
need to be further examined. (iii) Do the bases in the loop of stem-loop III serve a 
specific function? Inasmuch as loops (terminal and internal) and bulges within 
RNA often function as protein binding sites (Nowakowski et al. , 1 997), the 
function of the terminal loop sequence will need to be evaluated. (iv) Does the 
intra-5 '  UTR ORF affect replication through a cis-acting influence on translation? 
Several short upstream ORFs have now been shown to profoundly influence the 
translation of downstream ORFs in eukaryotic and viral RNAs through a variety 
of mechanisms (Gabelle, 1 996; Mathews, 1 996; Morris et al. , 2000). Inasmuch as 
the replication of some group 2 DI RNAs show a cis-preference for translation 
(Chang et al. , 1 996; van der Most et al. , 1 995), a parallel may exist in genome 
replication. If so, the influence of a genomic upstream ORF may significantly 
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affect genome replication. Certainly, a short intraleader ORF in a mutant BCoV 
genome that arose during persistent infection in cell culture had a measurable 
effect on the translation from an ORF 1 start codon in vitro (Hofmann et al. , 
1 993). Curiously, none of the stem-loop III-associated ORFs begin within a 
highly favorable Kozak context (Kozak, 1 994; Table 2.2) suggesting that 
translation from this ORF may not need to be efficient to fulfill a translational 
requirement. In addition, our results showing that at least some molecules with a 
totally foreign short ORF (i.e., the ORF beginning at nt 99 in pSLIII-mutl L/R in 
Fig. 2.2) can replicate indicates that perhaps any ORF and not necessarily only the 
wt ORF can suffice. In this regard, it would seem possible that an inefficient start 
codon such as CUG (Peabody, 1 989) at position 9 1  (Fig. 2. 1 ), which is in frame 
with the wt short ORF, could suffice for replication and maybe this is what 
initiates the ORF function for the replicating progeny of mutant pSLIII-mut4L/R 
in which a non-start AaG (lys) codon is found at position 100 (Fig. 2.5 B). If this 
is true, then perhaps the function of the short ORF in replication is necessary and 
not just preferred for replication. In this regard, it is also curious that a short 5' 
UTR-positioned ORF in the equine arteritis virus appeared to have no effect on 
the replication of this Nidovirus in cell culture (Molenkamp et al. ,  2000). It is a 
remote possibility, suggested by the results of our experiments with the AcG 
codon, that a weak start codon such as GUG (Peabody, 1 989) used in the equine 
arteritis virus experiments (Molenkamp et al. , 2000) could have sufficed to 
initiate a required translation function of the short ORF. (v) Does stem-loop III 
function as a packaging signal? Inasmuch as our assay measured the character of 
VPl (packaged) molecules, our results would have been influenced by a 
packaging function of stem-loop III. Thus, despite the mapping of a BCo V 
packaging signal within ORF 1 b at genome nt positions 20,049-20, 1 1 7 
(Chouljenko et al. , 2001 ; Cologna et al. , 2000; and K. Nixon and D. Brian, 
unpublished data), a sequence not present in the BCoV DI RNA studied here, the 
role of stem-loop III in DI RNA packaging should be examined. It should be 
noted, however, that with no mutant did we see abundant accumulation at 24 and 
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48 hpt and a low accumulation in VP 1 making it unlikely that a disrupted 
packaging signal explains the low levels in VPl observed in Figs. 2. 1 and 2.2. 
The question of what constitutes the cis-acting elements for coronavirus 
RNA replication is especially relevant to an earlier postulate that coronavirus 
subgenomic (sg) mRNAs behave as replicons in the presence of trans-acting viral 
RdRp (Sethna et al. , 1 989). Whereas the postulate is consistent with the 
observations that (i) the termini on sgmRNAs are theoretically large enough to 
serve as RdRp promoters for replication (a 5 '-terminal region of 65 to 95 nts and a 
3 '-terminal region of ~300 nts [Cavanagh, 1 997; Lai et al. , 1 997; van der Most et 
al. , 1 995]) (both of which greatly exceed the sizes of alphavirus and myxovirus 
replication promoters [Levis et al. , 1 986; Li et al. , 1 992]), (ii) coronavirus 
sgmRNAs have minus-strand counterparts (Hofmann et al. , 1 990; Sethna et al. , 
1 991 ; Sethna et al. , 1 989) capable of forming mRNA-length, double-stranded 
(apparent) replicative intermediates (Barie et al. , 1 987; Barie et al. , 2000; 
Hofmann et al. , 1 990; Sawicki et al. , 1 990; Sawicki et al. , 1 995; Sawicki et al. , 
2001 ; Sethna et al. , 1 997; Sethna et al. , 1 991 ; Sethna et al. , 1 989), and (iii) 
sgmRNAs accumulate faster than genome at early times after infection (Hofmann 
et al. , 1 990; Sethna et al. , 1 989), the hypothesis has not been supported by 
experiments that directly measure sgmRNA accumulation following transfection 
into helper virus-infected cells (Chang et al. , 1 994; Makino et al. , 1 99 1 ). For 
BCoV, the replicating DI RNA differs from sgmRNA 7 by only 42 1 nts, the first 
1 3  7 of which come from nts 7 4 through 2 1 0  in the genomic 5 '  UTR and the 
second 284 of which come from the 5 '  end of ORF l a  (Chang et al. , 1 994) . 
Assuming mRNAs do not replicate as indicated by the results of transfection 
experiments (Chang et al. , 1 994; Makino et al. , 199 1  ), then elements mapping 
within the 5 '-proximal 42 1  nts in BCoV DI RNA but absent in subgenomic 
mRNAs must be providing at least part of what is needed for replication. Stem­
loop III described here appears to be one of these elements. 
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CHAPTER III. VIRAL AND CELLULAR PROTEIN 
INTERACTIONS WITH STEM-LOOP III IN THE BOVINE 
CORONA VIRUS GENOMIC 5' UNTRANSLATED REGION. 
INTRODUCTION 
5'-proximal cis-acting elements required for bovine coronavirus (BCoV) 
defective interfering (DI) RNA replication have been shown to includ� two 
higher-order structures identified as stem-loops III (Chapter II; Raman et al., 
2003) and IV (Chapter IV) mapping mostly within the 5' untranslated region (5' 
UTR). Stem-loop III shows phylogenetic conservation as an element in group 2 
corona viruses, has a possible analog if not homo log in corona virus groups 1 and 
3, and has associated with it in all coronaviruses for which sequence is known a 
short intra-5' UTR open reading frame (Chapter II; Raman et al., 2003). A stem­
loop III analog with these properties appears in the SARS coronavirus genome as 
well (Raman and Brian, unpublished; Appendix). The higher-order structure of 
stem-loop III was shown to be required for DI RNA replication and the stem-loop 
III-associated intra-5' UTR was shown to enhance DI RNA accumulation but not 
to be an absolute requirement for replication (Chapter II; Raman et al., 2003). 
The potential for stem-loop III to bind proteins has not been reported. Stem-loop 
IV has been shown to function as a higher-order structure in the positive strand 
and to bind as a higher-order element eight cellular proteins in the molecular 
weight range of 75 to 25 kDa molecular weight (Chapter IV). 
Few studies have described the association of viral or cellular proteins 
with the 5' UTR of coronavirus genomic RNA. One characterized interaction is 
that of viral nucleocapsid (N) protein with leader sequence in MHV-JHM (Nelson 
et al., 2000; Stohlman et al., 1988). Its strong interaction, a measured Kd of 14 
nM, was shown to be dependent on the leader-associated AAUCY AAAC 
sequence mapping at nts 68 through 76, and cellular mRNAs with this binding 
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region experimentally engineered into the 5 '  UTR experienced an advantage in 
translation over cellular mRNAs lacking this sequence in MHV-infected cells 
(Nelson et al., 2000; Stohlman et al. ,  1 988). The binding region for this 
interaction within the 455 amino-acid N protein mapped at amino acid residues 
1 77 through 23 1 (Nelson et al. , 2000). In MHV-JHM, a 55 kDa cellular protein 
has been found to bind nts 56 through 1 1 2 in the genomic 5 '  UTR and cellular 
proteins of 3 8 kDa and 3 5 kDa bind to the minus-strand counterpart of this 
sequence (Furuya et al., 1 993). This region includes the upstream 1 5  nts of the 
20-nt stem-loop III in MHV-JHM and could theoretically form a part of stem-loop 
III with a three base-paired stem and a free energy of -4.0 kcal/mole in the 
positive-strand and -4. 1 kcal/mole in the negative-strand. To our knowledge no 
description has yet been made for any coronavirus of viral proteins binding to the 
5 '  UTR in the region encompassed by stem-loop III. 
Here, we extend our earlier studies on stem-loop III in the BCoV DI RNA 
(Chapter II; Raman et al., 2003) to determine in which strand, positive or 
negative, it functions in replication, and whether proteins if any interact with the 
active structure(s). We present data showing (i) that stem-loop III functions in 
both the positive and negative-strand orientations, (ii) that viral N protein, and 
another viral protein or virally induced or modified cellular protein of 
approximately 22 kDa molecular weight specifically bind stem-loop III in the 
positive strand in a higher-order structure-dependent manner, and (iii) that seven 
cellular proteins in the molecular weight range of 76 to 25 kDa specifically bind 
stem-loop III in the negative strand in a higher-order structure-dependent manner. 
MATERIALS AND METHODS 
Virus and Cells. A DI RNA-free stock of the Mebus strain of BCoV at 4.5 
X 1 08 PFU/ml was prepared and used as a helper virus as previously described 
(Chang et al. ,  1 994; Raman et al., 2003). The human rectal tumor cell line HRT-
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18 (Tompkins et al., 1974) was used as previously described (Chang et al., 1994; 
Raman et al., 2003). 
Plasmid constructs. Construction of pGEM3Zf(-) (Promega)-based pDrep 
1 (Chang et al., 1 994) and its stem-loop III mutant derivatives pSLIIl-mut2L, 
pSLIII-mut2R, pSLIII-mut2L/R, and pSLIII-mut4L/R (Table 3. 1 )  have been 
previously described (Chapter II). To construct the additional mutant derivatives 
used in this study, overlap PCR mutagenesis (Horton et al., 1 990) was used with 
plasmid DNA and the oligonucleotides described in Table 3.2. The strategy for 
constructing the mutants was the same as that used for pSLIII-mutGU except for 
the differences noted. For making pSLIII-mutGU, primers Ndel (+), SRST3GU(­
), and pDrep l DNA were used in the first PCR, primers SRST3GU(+), GEM3Zf(­
)Ndel (-), and pDrepl DNA were used in the second PCR, and primers GEM3Zf(­
)Ndel (-) and Ndel (+) and the products of the first two reactions were used in a 
third PCR to make a 1 , 1 83-nt product that was trimmed to 693 nts with restriction 
endonucleases NgoM IV and Avr II and cloned into NgoM IV/Avr II-linearized 
pDrepl .  For making pSLIII-mutCA, SRST3CA(-) replaced SRST3GU(-) in the 
first PCR, and SRST3CA(+) replaced SRST3GU(+) in the second PCR. 
For making pSLIII(PB), a construct from which 1 20-nt T7 RNA 
polymerase-generated transcripts of wt positive-strand stem-loop III-containing 
RNA for protein binding studies can be made, a three step procedure was used: 
(i) An EcoR V restriction endonuclease site was engineered at nt 3 in pDrep 1 to 
create pDrepEcoR V3. For this, overlap PCR mutagenesis was used in which 
Ndel (+), SRECOR5(-) and pDrep l DNA were used in the first PCR, 
SRECOR5(+), GEM3Zf(-)Ndel (-) and pDrepl DNA were used in the second 
PCR, and GEM3Zf(-)Ndel (-), Ndel (+) and the products of the first two reactions 
were used in a third PCR to make a 1 ,  183-nt product that was trimmed to 693 nts 
with restriction endonucleases NgoM IV and Avr II and cloned into NgoM 
IV/Avr II-linearized pDrepl .  (ii) A second EcoR V restriction endonuclease site 




Table 3 . 1 .  S fBCoV st III mutant - -
Mutant Sequence in stem-loop III mutant Property of stem-loop III kcal/ kcal/ Replic- Number of UV 
name in positive strandb mutant mole mole ationd crosslinked protein 




pSLIII -UCUAUGCUUGUGGGCGUAGA- wt -9. 1 -3 .0 yes 3 2 
(wt) 
pSLIII- -UCUAUGuUUGUGGGCGUgGg- Stem-loop retained in (+) -5 .4 no no 3 2 
mutGU but not ( -) strand. struct. 
pSLIII- -cCcAUGCUUGUGGaCGUAGA- Stem-loop retained in (-) no -0.9 no 3 0 
mutCA but not ( +) strand. struct. 
pSLIII- -agaAUGggUGUGGGCGUAGA- Stem is disrupted in ( +) no no no 3 0 
mut2L and (-) strands. struct. struct. 
pSLIII- -UCUAUGCUUGUGucCGUucu- Stem is disrupted in ( +) no no no 4 2 
mut2R and (-) strands. struct. struct. 
pSLIII- -agaA U GggUGU GucCG U ucu- Stem is re-formed in ( +) - 1 0.0 -3 . 2  yes 3 2 
mut2L/R and ( -) strands .  
pSLIII- -UCUuaGCUUGUGGGCuaAGA- AUG in stem changed to -9.3 -7.4 no 3 2 
mut4L/R UAG 
pSLIII- -UCUAUGCUUGUGucCGUuugUc- Stem III and alternate stem no no NIA 4 0 
mut3R are disrupted. struct. struct. 
a. Mutants of stem-loop III in BCoV DI RNA examined in Chapter II and in this study. Throughout the text wild type and 
mutants are abbreviated wt, mutGU, mutCA, mut2L, mut2R, mut2L/R, mut4L/R, mut3R. T7 RNA polymerase-generated 




Table 3.1. Continued . 
b. Represents nts 97-116 in BCoV DI RNA, except for mutant pSLIII-mut3R in which the sequence represents nts 97-118. The 
underlined AUG is the start codon for the intraleader short ORF. 
c. Free energy calculated for the stem-loop via the Zuker algorithm. 
d. Said to be replicating if the mutant form is present in cells infected with passage one virus following transfection. Replication 
studies of mutants mut2L, mut2R, mut2L/R, and mut4 L/R were described in Chapter II. 
e. Determined in this study. 
� 
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Table 3 .2. or 
Oligonucleotide8 
GEM3Zf(-) 
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CCTCCAAATCATATGGACGTGTATTC 456-481  
CCACTCCCTGTATTCTATGtTTGTGGGCGTgGgTTTTTCATAGTGGTGTC 84- 1 33 
GACACCACTATGAAAAAcCcACGCCCACAAaCATAGAATACAGGGAGTGG 84- 1 33 
CATCCACTCCCTGTATcCcATGCTTGTGGaCGTAGATTTTTCATAGTGG 8 1 - 1 29 
CCACTATGAAAAATCTACGtCCACAAGCATgGgATACAGGGAGTGGATG 8 1 - 1 29 
GTGAATTGTAATACGACTCACTATAGATatcGAGCGATTTGCGTGCGTGC 3 1 75c 
25 
GCACGCACGCAAA TCGCTCgatA TCT AT AGTGAGTCGTATT ACAA TTCAC 3 1 75c -
25 
GATCTCTTGTT AGATCTTTTT AT AgatatcACTTT AT AAAAACA TCCACTCCCTG 39-93 
CAGGGAGTGGATGTTTTTATAAAGTgatatcTATAAAAAGATCTAACAAGAGATC 39-93 
GATTGTGAGCGATTTGCGTGCGTGC 1 -25 
CACTCCCTGT ATagaATGggTGTGtcCGTtct 85- 1 1 6  
agaACGgaCACAccCA TtctA T ACAGGGAGTG 85- 1 1 6  
CACTCCCTGT ATagaATGggTGTGGGCGT AGA 85- 1 1 6  
TCT ACGCCCACAccCA TtctAT ACAGGGAGTG 85- 1 16  
GTATTCT ATGCTTGTGtcCGTtctTTTTTCAT AGTGG 93- 129 
CCACT ATGAAAAAagaACGgaCACAAGCAT AGAA TAC 93- 129 
GTATTCTATGCTTGTGtcCGTttgTcTTTCATAGTGG 93- 1 29 
CCACTATGAAAgAcaaACGgaCACAAGCATAGAATAC 93- 1 29 
.i::,. 
00 
Table 3 .2. Continued. 
Oligonucleotide8 Polarity Sequence (5' ->3'l Binding region in 
pDrepl 
SRUTRSTOP(-) + CCACTCCCTGT A TTCTtaGCTTG TGGGCtaAGA TTTTTCAT AGTG 84- 1 28 
SRUTRSTOP(+) - CACT ATGAAAAA TCTtaGCCCACAAGCtaAGAA T ACAGGGAGTGG 84- 128 
TGEV8(+) - CATGGCACCATCCTTGGCAACCCAGA 1 098- 1 1 23 
TGEV8b(+) - CATGGCACCATCCTTGGCA 1 1 05- 1 1 23 
a. The positive and negative symbols in the oligonucleotide names indicate the polarity of the nucleic acid to which the 
oligonucleotide anneals . 
b. Lowercase bases represent mutated sites. 
c. Indicates nucleotide positions in the pGEM3Zf(-) vector. 
used except that SRECORV70(-) replaced SRECOR5(-) and pDrepEcoRV3 DNA 
replaced pDrep 1 DNA in the first PCR, and SRECORV70( +) replaced 
SRECOR5(+) and pDrepEcoRV3 DNA replaced pDrep l DNA in the second 
PCR. (iii) pDrepEcoRV65 DNA was digested with EcoR V to remove nts 4 
through 65 and the ends of the remaining fragment were ligated resulting in 
pSLIII(PB). In construct pSLIIl(PB), wild type nts 66UAA were changed to 
66AUC. 
The strategy for constructing each of the following mutants from which 
1 20-nt T7 RNA polymerase-generated transcripts can be made was the same as 
that used for pSLIII-mut2L(PB) except for the differences noted. For making 
pSLIII-mut2L(PB), primers Nde l (+), SRST3L(-), and pSLIII(PB) DNA were 
used in the first PCR, primers SRST3L(+), GEM3Zf(-)Ndel (-), and pSLIII(PB) 
DNA were used in the second PCR, and primers GEM3Zf(-)Nde l (-) and Nde l (+) 
and the products of the first two reactions were used in the third PCR to make a 
1 ,  1 2 1 -nt product that was trimmed to 63 1 nts with restriction endonucleases 
NgoM IV and Avr II and cloned into NgoM IV/Avr II-linearized pDrepl .  For 
making pSLIII-mut2R(PB), SRST3R(-) replaced SRST3L(-) in the first PCR, and 
SRST3R(+) replaced SRST3L(+) in the second PCR. For making pSLIII­
mut2L/R(PB), SRST3double(-) replaced SRST3L(-) and pSLIII-mut2R(PB) DNA 
replaced pDrep l DNA in the first PCR, and SRST3double(+) replaced 
SRST3L(+) and pSLIII-mut2R(PB) DNA replaced pDrepl DNA in the second 
PCR. For making pSLIII-mut4L/R(PB), SRUTRSTOP(-) replaced SRST3L(-) in 
the first PCR, and SRUTRSTOP(+) replaced SRST3 L(+) in the second PCR. For 
making pSLIII-mutGU(PB), SRST3GU(-) replaced SRST3L(-) in the first PCR, 
and SRST3GU(+) replaced SRST3L(+) in the second PCR. For making pSLIII­
mutCA(PB), SRST3CA(-) replaced SRST3L(-) in the first PCR, and 
SRST3CA(+) replaced SRST3L(+) in the second PCR. For making pSLIII­
mut3R(PB), SRST3RALT(-) replaced SRST3L(-) in the first PCR, and 
SRST3RALT(+) replaced SRST3L(+) in the second PCR. 
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For making pSLIII-minus(PB), pSLIII-mutGUminus(PB) and pSLIII­
mutCAminus(PB) from which 130-nt SP6 RNA polymerase-generated negative­
strand stem-loop III-containing transcripts can be made, pSLIII(PB), pSLIII­
mutGU(PB), and pSLIII-mutCA(PB), respectively, were digested with Hpa I and 
Miu I to remove nts 153 through 2,231 and the ends of the remaining fragments 
were ligated. 
Northern assay for DI RNA replication. The Northern assay was 
performed as previously described (Chapter II) . 
Sequence analysis of the stem-loop III region in progeny DI RN As. For 
direct sequencing of asymmetrically-amplified cDNA, the procedure as described 
by Hofmann et al (Hofmann et al., 1993) for analysis of plus-strand RNA was 
used as previously described (Chapter II) . Briefly, oligonucleotides TGEV8b(+) 
and SRleader(-) were used for RT-PCR with RNA extracted at 48 hpi from cells 
infected with the first passage virus (VPl ), and 5'end-radiolabeled 
oligonucleotide SRleader(-) was used for sequencing. 
RNA-protein binding assays. Preparation of cell lysates and the 
electrophoretic mobility shift assays (EMSAs) essentially followed the procedures 
of Gamamik and Andino (Andino et al. , 1990; Gamamik et al. , 1997). The 
method for probe elution from preparative gels was that of Thomson et al 
(Thomson et al., 1999). For preparation of cell lysate, freshly confluent HRT 
cells (~1.2X106 cells per 35mm dish) were either mock infected, or infected with 
BCo V at a multiplicity of 10 PFU per cell, and processed as individual plates. 
Cells were washed and harvested at 6 hours post infection ( or equivalent time in 
mock-infected cells) in ice cold phosphate buffered saline (PBS) by scraping and 
centrifuging at 600 X g for 4 minutes, resuspended in 4 packed cell volumes of 
hypotonic lysis buffer (5 mM HEPES [pH 7.9], 25 mM KCl, 2 mM MgCh, 4% 
glycerol, 20 mM DTT, 0.1 mM PMSF, 0.2 mM EDTA, 1 % [v/v] NP-40), kept on 
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ice for 20 minutes, lysed by douncing with 30 strokes in a tight-fitting Dounce 
homogenizer, and nuclei were removed by centrifugation at 700 X g for 10 
minutes. The protein in clarified lysate was quantitated with the Bradford kit 
from BioRad and lysate was divided into 10 ul aliquots containing 20 ug total 
protein each and stored at -80° C until use. 
To synthesize positive-strand radiolabeled RNA probes for EMSAs and 
crosslinking studies, pSLIII(PB) and mutant constructs pSLIII-mut2L(PB), 
pSLIII-mut2R(PB), pSLIII-mut2L/R(PB), pSLIIl-mut4 L/R(PB), pSLIII-
mutGU (PB), pSLIII-mutCA(PB), and pSLIII-mut3R(PB) were linearized with 
restriction endonuclease A vr II and transcribed using T7 RNA polymerase in a 50 
ul reaction volume containing 120 uCi of a-32P-UTP (300 Ci/mmol). For 
synthesis of negative-strand radiolabeled RNA probes, the same radiolabeling 
procedure was used except that pSLIII-minus(PB) and mutant constructs pSLIII­
mutGUminus(PB) and pSLIII-mutCAminus(PB) were linearized with restriction 
endonuclease EcoR V and transcribed with SP6 RNA polymerase. Radiolabeled 
transcripts were purified by electrophoresis on an 8 M urea 6% polyacrylamide 
gel (Andino et al., 1990) and recovered by elution (Thomson et al., 1999). 
Unlabeled transcripts used as competitor RNA were chromatographed through a 
Biospin 6 column (BioRad). 
For EMSA, 1Xl 04 cpm of 32 P-UTP-labeled probe, and unlabeled 
competitor RNAs when used, were incubated in renaturation buffer (20 mM 
HEPES [pH 7.9], 60 mM KCl, 2 mM MgC}i) for 30 minutes at 45° C prior to 
addition to a binding reaction mixture. For the binding reaction, the cell lysate (in 
10 ul) was preincubated for 10 min at 30°C after the addition of 1 ul tRNA at 10 
ug/ul, 1 ul PMSF at I 00 mM, and 1 ul heparin at I ug/ul. After addition of the 
radiolabeled probe in approximately I ul, the mixture was incubated at 30° C for 
IO  min at which time 2 ul of 50% glycerol was added and the products were 
electrophoretically separated on a 6% native polyacrylamide/5% glycerol gel at 4° 
C in 0.5 X TBE ( 1  X TBE = 0.9 M Tris [pH 8.0] ,  0.09 M boric acid, 0.002M 
5 1  
EDT A) electrophoresis buffer. In the competition assays, 5, 1 0, or 1 5  ug of 
unlabeled probe RNA, or 5, 1 0, or 1 5  ug unlabeled yeast tRNA were used. 
For the supershift assays, 2 ul of antiserum ( containing approximately 40 
ug of protein total) was added to the reaction mixture in one set before and in 
another set after completion of the RNA-protein binding reaction and the mixture 
was incubated on ice for 30 minutes prior to electrophoretic separation (Andino et 
al., 1 990; Gutierrez-Escolano et al., 2000). Rabbit polyclonal anti-N and 
preimmune sera (Hogue et al., 1 984), rabbit polyclonal anti Poly (C)-binding 
protein (PCBP)-2 and preimmune sera (Blyn et al. ,  1 997) (kind gifts from E. 
Ehrenfeld, U. C. Irvine), and mouse polyclonal anti-La antiserum (obtained from 
BD Biosciences) were used. 
For UV cross-linking and molecular weight determinations the method of 
Pestova et al was used (Pestova et al., 1 99 1 ). For this, RNA-protein binding 
reaction mixtures were irradiated at 3 mwatts/cm2 on ice for 30 minutes in a 
Stratalinker UV cross linker 1 800 (Stratagene) and the preparation was digested 
with a mixture of 100 U of RNase T l ,  2.5 U of RNase A and 1 U of RNase CVl 
(Ambion) for 40 minutes at 37° C. Protein molecules radiolabeled by virtue of 
the cross-linked probe fragments were electrophoretically separated by SDS 
PAGE on a gel of 1 0% polyacrylamide. Gels were dried and analyzed with a 
Packard Instantlmager Autoradiography System for quantitation and exposed to 
Kodak XAR-5 film for 1 to 10  days at -80°C for imaging. Images were recorded 
by digital scanning of the film. 
Accession numbers. The GenBank accession number for BCoV-Mebus is 
U00735 .  
RESULTS 
Integrity of stem III in both the positive and negative strands is required 
for BCo V DI RNA replication. The rationale applied here for evaluating the 
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functional importance of a higher-order RNA element in DI RNA replication has 
been previously described (Chapter II) . Briefly, an element was judged necessary 
for replication if mutations in structure led to a loss of DI RNA accumulation at 
24 and 48 h post transfection and an absence of mutant progeny molecules in VP l 
RNA. In the case of disrupted helical elements, restoration of some level of DI 
RNA accumulation and the presence of the double mutant in cells infected with 
VPl following a compensatory restoration of helix structure were also criteria 
used. Replicating DI RNA molecules with wt structure in VPl originating from 
mutant constructs were judged to be the result of recombination between input DI 
RNA and the 5' end of the helper virus genome (Chapter II). 
Analysis of base pair covariations within stem-loop III among group 2 
coronaviruses shows maintenance of stable higher-order structure in both the 
positive (free energy range, - 1 1 .5 to -5 . 1  kcal/mole) and negative (free energy 
range, -9.3 to -3 .0 kcal/mole) strands (Chapter II). The question of which strand 
stem-loop III functions in replication was not answered by stem disruption 
experiments described previously (Chapter II) since negative free energy values 
were maintained in both the positive and negative strands in all replicating 
mutants, and higher-order structures were simultaneously disrupted in both 
strands in the non-replicating mutants. Therefore, to test the strand requirements 
in stem-loop III for DI RNA replication, mutations were made in pDrep 1 such 
that higher-order structure was selectively destabilized in either the negative 
(mutGU) or positive (mutCA) strand on the basis of m-fold predictions 
(http://bioinfo.math.rpi.edu/~zukerm/; Mathews et al. , 1 999; Zuker et al. , 1 999) 
and transcripts were tested for replication (Table 3 . 1 ;  Fig. 3 . 1 ). For mutGU, 
Northern analysis showed 1 7  % of wt levels at 24 hpt, 20 % at 48 hpt, and 1 5  % at 
48 hpi in VP 1 RNA, and sequence analysis of the asymmetrically-amplified 
cDNAs from VP l RNA showed all progeny to be wild type indicating transcripts 
of mutGU had not replicated (Fig. 3 . 1  ). For mutant mutCA, Northern analysis 
showed an accumulation of 1 5  % of wt levels at 24 hpt, 2 1  % at 48 hpt and 8 % in 



































C A  ...: C 































<: Predicted .c: .c: T"" ...: z .c: v co a. nt seq. short ORF 
E 0::: T"" N v > in VP 1 product 
- ·-- wt MLVGVDFS �. . � ' 
1 00% 1 00% 1 00% 1 00% 
<: T"" .c: .c: 
z .c: v co a. 
0::: N v > -'>1�" ·. ·. , ., • all wt MEVGVQ.FS 
25% 1 7% 20% 1 5% 
<: .c: .c: a:: z .c: v co 
0::: T"" N v > 
• - .... - all wt MLVQVDFS 
1 05% 1 5% 21% 8% 
Fig. 3.1. Integrity of stem III in both the positive and negative strands is 
required for DI RNA replication in helper virus-infected cells, as 
determined by analysis of mutant variants of pDrep 1. The mfold­
predicted structures of wt (pDrepl )  and mutants (pSLIII-mutGU and 
pSLIII-mutCA) transcripts in the positive and negative strands and their 
calculated free energies in kcal/mole are shown. Mutated bases are 
shown as lowercase letters. The start codon for the intra-5' UTR ORF is 
boxed. Accumulation was measured by Northern analysis with a 
reporter-specific radiolabeled oligonucleotide. For Northern analyses, 
T7 RNA polymerase-generated transcripts of linearized plasmids were 
transfected into BCoV-infected cells and RNA was extracted at the 
indicated times post transfection and at 48 h post infection with virus 
passage 1 (VP 1 ). Accumulation of pDrep 1 progeny was considered to be 
100%. The sequence of the RNA in VP 1 progeny replicons was 
determined by bulk RT-PCR sequencing using pDrep I -specific primers 
as described in the text. Lanes : Uninf., mock infected, non-transfected 
cells; Inf., infected, non-transfected cells; RNA, sample of the transcript. 
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indicating this mutant also had not replicated (Fig. 3 . 1  ). Although the amino acid 
sequence encoded by the stem-loop III-associated short ORF in both mutants was 
not wt (Fig. 3 . 1  ), it is not likely that these differences would have blocked 
replication since amino acid differences from wt were shown to be tolerated in 
our earlier studies (Chapter II). Taken together these results indicate that the 
integrity of stem-loop III in both the positive and negative strands is required for 
DI RNA replication. 
Viral or virally induced or modified cellular proteins of approximately 55 
and 22 kDa molecular weight bind specifically to stem-loop II I  in the positive 
strand. To test the hypothesis that stem-loop III functions in the positive strand 
through interactions with cellular or viral proteins, EMSAs were done with 
radiolabeled 1 20-nt transcripts in which the 20-nt wt stem-loop III was flanked 
upstream by 34 and downstream by 66 nts (Fig. 3 .2). Two isoforms of the free 
probe were produced, a not uncommon phenomenon (Black et al., 1 998), t�at 
may reflect alternate folding of the probe molecule. On incubation with lysate 
from uninfected cells one band of shifted probe identified as complex I was 
evident (Fig. 3 .2, lane 4 vs lane 1 )  whereas from BCoV-infected cells (lane 3) a 
second shifted band identified as complex II was also evident. Elimination of 
probe shifting by proteinase K treatment (lane 2) identified the binding molecule 
as protein. These results suggest that1complex I was formed by probe interactions 
with a cellular protein(s) and complex II with cellular and viral protein(s), 
although in the second instance interactions with virally-induced or virally­
modified cellular proteins was also a possibility. The likelihood that complex II 
resulted from the products of virus-induced transcription of cellular genes, 
however, seems unlikely since BCoV infection induces a potent 24 h transient 
inhibition of host transcription as measured by pulse-chase labeling experiments 
in HRT cells (unpublished data). The interaction in both complexes was specific, 
furthermore, since addition of increasing amounts of unlabeled probe as 
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Complex 1 1 [ 
Complex I [ 
Free probe 
competitor RNA 
1 SLI I I  RNA (wt) tRNA 
re::::::::::::: � 
2 3 4 5 6 7 8 9 1 0  
Fig. 3 .2 .  Both cellular and viral proteins bind specifically to 
positive strand stem-loop III-containing RNA. A uniformly 
labeled 120 nt stem-loop III-containing positive strand RNA 
probe was used in electrophoretic mobility shift assays as 
indicated. Two isoforms of the probe were present. Probe 
treatments : Lane 1 ,  incubated with buffer; lane 2, incubated with 
proteinase K-treated infected cell lysate; lane 3, incubated with 
infected cell lysate; lane 4, incubated with uninfected cell lysate; 
lanes 5-7, incubated with infected cell lysate to which had been 
added 5, 1 0, and 1 5  ug of unlabeled probe RNA, respectively; 
lanes 8- 1 0, incubated with infected cell lysate to which had been 
added 5, 1 0, and 1 5  ug yeast tRNA, respectively. 
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competitor reduced complex formation in a dose dependent manner (Fig. 3 .2, 
lanes 5 to 7) whereas addition of tRNA, a presumed nonspecific competitor, did 
not (lanes 8 to 1 0). These results together suggest that the positive-strand of 
stem-loop III is able to complex with both cellular and viral or virally induced or 
modified cellular proteins. 
To determine whether the proteins are binding the 20-nt stem-loop III 
element, and, simultaneously, to establish whether binding is specific to its 
higher-order structure, EMSAs were done in a way that compared wt stem-loop 
III to its mutant forms (Chapter 11; summarized in Table 3 . 1 )  (Fig. 3 .3). Probes 
from all three mutants with a predicted higher-order structure, namely mut2L/R 
(Chapter II, Fig. 2.3), mut4L/R (Chapter II, Fig. 2 .5 B) and mutGU (Fig. 3 . 1  ), 
were shifted to form complex I with lysates from uninfected cells (Fig. 3 .3 A, lane 
5 and Fig. 3 .3 B, lanes 5 and 9) and complexes I and II with lysates from infected 
cells (Fig. 3 .3 A, lane 6 and Fig. 3 .3 B, lanes 6 and 10) as did probe from wt (Fig. 
3 .3 A, lanes 3 and 4, and Fig. 3 .3 B, lanes 3 and 4). Probes from mut2L (Chapter 
II, Fig. 2.3) and mutCA (Fig. 3 . 1  ), on the other hand, with no predicted higher­
order structure were shifted to form only a poorly defined complex I with both 
uninfected and infected cell lysates (Fig. 3 .3 A lanes 8- 10, and 3 .3 B, lanes 1 1 -
1 3). Puzzlingly, probe from mut2R (Chapter II, Fig. 2.3) with a predicted 
disrupted stem-loop III structure formed a diffuse pattern of shifted probe that 
extended to the top of the gel (Fig. 3 .3 A, lanes 1 1  and 1 2). These results showed 
( with the exception of mut2R) there was a positive correlation between predicted 
wt-like higher-order structure in stem-loop III in the positive strand and the 
formation of a second RNA-protein complex ( complex II). 
To determine the number and sizes of proteins in the complexes, UV 
cross-linking between the radiolabeled RNA and proteins was done followed by 
RNase digestion and SDS PAGE (Fig. 3 .4). By these analyses, three faintly­
appearing cellular protein species of approximately 6 1 ,  48, and 36 kDa, and 
probably three more cellular proteins of approximately 45, 42, and 33 kDa in size 
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Fig. 3.3. Viral proteins bind specifically to stem-loop III RNA in a 
higher-order structure dependent manner ( except for construct 
mut2R). Electrophoretic mobility shift assays were done with 
radiolabeled transcripts made from the indicated wt and mutant 
constructs. All probes were 120 nts in length. In all cases two 
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Fig. 3 .4. Viral proteins of  approximately 55  and 22 kDa molecular 
weight bind specifically to stem-loop III in the positive-strand. UV cross­
linking was done on protein binding reactions prepared as described in 
Fig. 3 .2. Reaction products were then digested simultaneously with 
RNases T l ,  A and CV l ,  as described in the text and electrophoretically 
separated on 1 0% SDS-PAGE gels. Numbers to the right indicate 
molecular weight positions as determined by molecular weight markers, 
and to the left indicate estimated molecular weights of the radio labeled 
proteins. Cellular proteins are indicated by filled rectangles and viral 
proteins are indicated by filled arrowheads. B. 1 5  ug of yeast tRNA 
(lane 1 ), and 1 5  ug of wild type unlabeled probe RNA (lane 7) were 
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Fig. 3.4. Continued. 
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were observed with various degrees of resolution with lysates from uninfected 
cells with wt probe (identified as filled rectangles in Fig. 3 .4 A, lane 9, Fig. 3 .4 B, 
lane 3 and Fig. 3 .4 C, lane 2). Increasing the RNase concentration three-fold did 
not improve the resolution of the bands indicating poor resolution was probably 
not caused by incomplete digestion of large cross-linked RNA tags. From 
infected cells, proteins of approximately 55 and 22 kDa and probably a 38 kDa 
protein were additionally observed with wt probe (identified as filled arrowheads 
in Fig. 3 .4 A, lane 8, Fig. 3 .4 B, lanes 1 and 2, and Fig. 3 .4 C, lane 1 ) . Curiously, 
the abundance of some of the binding cellular proteins from lysates of infected 
cells appeared increased over uninfected cells. The elimination of bands with 
proteinase K (Fig. 3 .4 B, lane 4) confirmed their protein identity. Additionally, 
all proteins bound specifically to the stem-loop III probe since addition of 1 500-
fold excess unlabeled transcript (Fig. 3 .4 B, lane 7) but not tRNA (Fig. 3 .4 B, lane 
1 )  prevented crosslinking. 
In a pattern that reflected their results from EMSAs, probes from mutants 
that retained stem-loop III-like higher-order structure, namely, mut2L/R (Fig. 3 .4 
A, lane 1 ), mut4L/R (Fig. 3 .4 C, lane 5), and mutGU (Fig. 3 .4 B, lane 1 0), were 
bound by the six cellular protein species to varying degrees, and also by the 5 5 
and 22 kDa viral proteins (Fig. 3 .4A, lane 2, Fig. 3 .4 C, lane 4, and Fig. 3 .4 B, 
lane 9, respectively). Probe from mutants lacking a predicted higher-order 
structure, on the other hand, namely mut2L and mutCA (Chapter 11; Table 3 . 1 ;  
Fig 3 . 1  ), bound only the cellular proteins from both uninfected and infected cells 
(Fig. 3 .4 A, lanes 3 and 4, and Fig. 3 .4 B, lanes 6 and 8). As with the EMSA 
results, the exception to this correlation was mut2R (Fig. 3 .4 A, lane 6) in which 
the stem-loop III structure was predicted to be disrupted but which bound the 55 
and 22 kDa viral proteins. Curiously, mutant mut2R showed a pattern of protein 
binding that was different from any of the other constructs, and the amounts of 
cellular protein bound, at least for all but the 6 1  kDa species (Fig. 3 .4 A, lane 5), 
were inexplicably greater. These results, with the exception of mut2R, again 
show the binding of viral proteins to be a function of the higher-order structure of 
6 1  
stem-loop III. Further, the observation that protein binding to construct mut4L/R, 
in which the stem-loop III associated AUG codon was disrupted, was 
indistinguishable from that with wt stem-loop III (Fig. 3.4 C) indicated that the 5' 
UTR ORF pre se was not important for protein binding. 
Since the nonreplicating mut2R with a predicted stem-loop III-disrupted 
structure (Chapter II; Table 3. 1 )  was also bound by the putative 55 and 22 kDa 
viral proteins as noted (Fig. 3 .4 A, lane 6), it was postulated that there may exist 
an alternate higher-order structure that would function as binding sites for the 
viral proteins but would not necessarily as a result of that binding fulfill a 
replication function. To examine this possibility, the predicted folding of mut2R 
was re-examined with the mfold program of Zuker (Mathews et al., 1 999; Zuker 
et al. , 1 999). Whereas the wt stem III was disrupted in mut2R (Chapter II), a 
highly likely alternate stem-loop was found that mapped between nts 1 00 through 
142 (Fig. 3.5 B). To test that it is possibly this alternate structure that is 
recognized by the viral proteins, mut3 R (Fig. 3 .5 C) was made in which it was 
predicted that no higher-order structure resembling that of wt or mut2R would be 
retained and protein binding was examined (Fig. 3 .5 A, lanes 7 and 8). Whereas 
mut3R RNA showed the same pattern of cellular protein binding as did mut2R 
(Fig. 3.5, lane 8), it did not show binding by the 55 kDa viral protein (Fig. 3.5, 
lane 7). Proteins near the size of the 22 kDa protein were not resolved in this 
study so a conclusion about the binding of the 22 kDa viral protein could not be 
made. The elimination of bands with proteinase K (Fig. 3.5 A, lane 1 )  confirmed 
their protein identity. Additionally, all proteins bound specifically to the mut2R 
probe since addition of 1500-fold excess unlabeled mut2R transcript (Fig. 3.5 A, 
lane 3) but not tRNA (Fig. 3 .5 A, lane 2) prevented crosslinking. 
The positive correlation between viral protein binding to a higher-order 
wt-like structure of stem-loop III in the positive strand and replication would 
suggest viral protein binding in a higher-order-dependent manner is a mechanistic 
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Fig. 3 .5 .  Positive-strand transcripts of mut2R form an alternate higher­
order structure that binds the 5 5 kDa viral protein. UV cross-linking, 
RNase digestion and SDS-PAGE gel electrophoresis were done as 
described in Fig. 3 .4. Numbers to the right indicate molecular weight 
positions as determined by molecular weight markers, and to the left 
indicate estimated molecular weights of the radio labeled proteins. Cellular 
proteins are indicated by filled rectangles and viral proteins by filled 
arrowheads. The mfold-predicted structures of the mut2R alternate stem­
loop (part B), and mut3R (part C) and their calculated free energies in 
kcal/mole are shown. Mutated bases are shown as lowercase letters. The 
start codon for the intra-5 ' UTR ORF is boxed. A. 1 5  ug of yeast tRNA 
(lane 2), and 1 5  ug ofmut2R unlabeled probe RNA (lane 3) were incubated 
with the cell lysate prior to the addition of the radio labeled probe. 
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the non-replicating mut2R forms a predicted alternate higher-order structure that 
also binds viral proteins makes this conclusion less straightforward, but it is 
possible that the orientation of the bound viral proteins on the alternate stem-loop 
is stoichiometrically inappropriate to fulfill a replication function. 
The 55 kDa viral protein binding to stem-loop III in the positive strand is 
the nucleocapsid (N) protein. Of the predicted fully-processed protein products of 
the BCo V genome ( 1 8  nonstructural and 8 structural proteins), the abundant 50 
kDa [52 kDa reported molecular weight by SDS-PAGE (Laude et al., 1 995)] N 
protein is the most likely candidate for the bound 55  kDa mol. wt. viral protein. 
To test the hypothesis that it is, an electrophoretic mobility supershift assay was 
done on the RN A protein complex II with antiserum to BCo V N protein. A 
supershift of complex II to form a complex III with N immune (Fig. 3 .6, lanes 9 
and 10) but not N preimmune (Fig. 3 .6, lane 4) serum indicated this is the case. 
Probe incubated with proteinase K-treated lysate from infected cells to which 
either N immune (lane 3), or N preimmune (lane 1 1 ) had been added showed no 
shifting thus confirming the protein nature of the supershifting molecules. Taken 
together these data indicate that the 55 kDa binding protein from virus-infected 
cells is the viral N protein and suggest that stem-loop III might function as a cis­
acting element through its interactions, at least in part, with the N protein. 
Since the 47 kDa La protein and the 39 kDa poly(C)-binding protein 2 
(PCBP-2) are cellular proteins known to bind a number of viral RNA elements 
(Gamarnik et al., 1 998; Parsley et al ., 1 997; Yocupicio-Monroy et al., 2003 ; and 
references therein), the hypothe�is was tested by supershift assays with uninfected 
cell lysates that these were binding the positive-strand stem-loop III RNA. 
Supershifting of wt probe complex I with uninfected cell lysates was not observed 
with either antiserum to La (Fig. 3 .6, lanes 6 and 7) or to PCBP-2 (data not 
shown) indicating that La and PCBP-2 are not among the cellular proteins binding 
the stem-loop III element in the positive strand. 
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Fig. 3 .6. The 5 5  kDa viral protein binding to positive-strand stem-loop III is 
the N protein. The electrophoretic mobility supershift assay was done using 
either N or La antiserum as indicated in the figure. A 1 20 nt stem-loop III 
containing probe as described in Fig. 3 .2 was used. Probe treatments : Lane 1 ,  
incubated with buffer; lane 2, incubated with proteinase K-treated infected cell 
lysate to which La antiserum was added; lane 3, incubated with proteinase K­
treated infected cell lysate to which N antiserum was added; lane 4, incubated 
with infected cell lysate to which N preimmune serum was added; lane 5, 
incubated with uninfected cell lysate; lanes 6 and 7, incubated with uninfected 
cell lysate to which La antiserum was added either before (lane 6) or after 
(lane 7) the RNA-protein binding step; lane 8, incubated with infected cell 
lysate; lanes 9 and 1 0, incubated with infected cell lysate to which N 
antiserum was added either before (lane 9) or after (lane 1 0) the RNA-protein 
binding step; lane 1 1 , incubated with proteinase K-treated infected cell lysate 
to which N preimmune serum was added. 
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Seven cellular proteins but no viral proteins bind specifically to the 
negative-strand form of stem-loop III. Since the integrity of stem-loop III in the 
negative as well as positive strand was necessary for BCo V DI RNA replication 
(Fig. 3 .1 ), the hypothesis was tested by EMS As that it in the negative strand 
interacts with cellular or viral proteins as a possible mechanism of action. For 
this, pSLIII-minus(PB) was used with SP6 RNA polymerase to generate 
uniformly radiolabeled 1 30-nt probes of wt minus-strand stem-loop III RNA in 
which the 20-nt stem-loop was flanked upstream by 79 nts and downstream by 3 1  
nts. As with the positive-strand probes, two isoforms of the free probe were 
observed for wt and all mutants. With lysates of uninfected (Fig. 3 .7, lane 4) or 
infected (Fig. 3 .7, lane 
1
3) cells, wt probe formed two shifted bands of lower 
mobility identified as complexes I and I' . It is presumed that the two bands 
represent complexes with cellular proteins of different composition but it could 
alternatively reflect the behavior of the two isoforms of the probe. Elimination of 
probe shifting by proteinase K treatment (Fig. 3.7, lane 2) confirmed the protein 
nature of the probe-shifting molecule. The complexes, furthermore, were specific 
to stem-loop III-containing negative strand RNA since addition of increasing 
amounts of unlabeled probe as competitor reduced complex formation in a dose 
dependent manner (Fig. 3 .7, lanes 5 to 7) whereas addition of tRNA did not (lanes 
8 to 10). These results indicate that stem-loop III-containing negative-strand 
RNA was bound specifically by cellular but not by viral proteins to form two 
RNA-protein complexes. 
To determine whether the proteins are binding to the 20-nt negative-strand 
stem-loop III element and to establish whether the binding is specific to its 
higher-order structure, EMSAs were done that compared wt to mutGUminus 
which does not retain higher-order structure and mutCAminus which does (Table 
3 . 1 ;  Fig. 3.1). Interestingly, probes from mutGUminus were not bound by either 
cellular or viral proteins (Fig. 3 .8, lanes 5 and 6) whereas probes from wt (Fig. 
3 .8, lanes 3 and 4) and mutCAminus (Fig. 3.8, lanes 9 and 10) were bound only 
by cellular proteins to form the two RNA-protein complexes identified as I and I'. 
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Fig. 3.7. Cellular proteins bind specifically to negative-strand 
stem-loop III-containing RNA. A uniformly labeled 130 nt 
stem-loop III-containing negative strand RNA probe was used 
in electrophoretic mobility shift assays and probe treatments 
were as described in Fig. 3.2. Two isoforms of the probe were 
present. 
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Fig. 3 .8 .  Cellular proteins bind specifically to negative-strand stem­
loop III in a higher-order structure dependent manner. 
Electrophoretic mobility shift assays were done with radiolabeled 
transcripts made from the indicated wt and mutant constructs. All 
probes were 130 nts in length. In all cases two isoforms of the 
probe were present. Mutant names used in the figure are 
abbreviations. 
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These results indicate that cellular proteins bind the negative-strand form of stem­
loop III in a higher-order structure dependent manner. 
To determine the number and sizes of proteins in the complexes, UV 
cross-linking analyses were carried out. Protein patterns were found to be 
indistinguishable between uninfected and infected cells and showed binding by 
seven proteins with approximate molecular weights of 76, 66, 48, 45, 4 1 ,  33 and 
25 kDa (Fig. 3 .  9, lanes 5 and 6). These results were consistent with the identical 
EMSA patterns from uninfected and infected cell lysates (Fig. 3 .8, lanes 3 and 4) 
indicating that cellular but not viral proteins were binding to the minus-strand of 
stem-loop III. Elimination of all seven bands by proteinase K treatment (Fig. 3.9, 
lane 4) confirmed their protein identities. All seven proteins bound specifically 
since the addition of 1 500-fold excess of unlabeled transcript prevented complex 
formation (Fig. 3 .9, lane 7) whereas the same amount of yeast tRNA did not (lane 
2). Furthermore, the binding of all seven proteins to minus strand was found with 
the mutations that maintained the higher-order structure (mutCAminus, Fig. 3 .9, 
lane 1 )  but not with those mutations that disrupted it (mutGUminus, Fig. 3 .9, lane 
3). 
Taken together, these data suggest that the seven proteins with molecular 
weights of 76, 66, 48, 45 , 4 1 , 33 and 25 kDa interact specifically with the higher­
order structure of stem-loop III in the negative strand and that this interaction may 
reflect a mechanistic feature of stem-loop III. 
DISCUSSION 
Previous studies on stem-loop III had shown it to function as a cis-acting 
element in BCoV DI RNA replication and that maintenance of an intra-5 '  UTR 
ORF of 24 nt was strongly preferred but not absolutely required for DI RNA 
replication (Chapter II; Raman et al. , 2003). Here, we show by mutational 
analyses in DI RNA that stem-loop III, as a higher-order structure, functions in 















inf. cell lysate 
+ 
+ 
uninf. cell lysate 
proteinase K 
mutCA wt mutGU wt wt 
minus minus minus minus minus M 












• 20. 1 
>� 
2 3 4 5 6 7 8 
Fig. 3 .9. Seven cellular proteins bind specifically to stem-loop III 
negative-strand RNA. UV cross-linking was done as described in 
Fig. 3 .4. Numbers to the right indicate molecular weight positions 
as determined by molecular weight markers, and to the left 
indicate estimated molecular weights of the radio labeled proteins. 
1 5  ug of yeast tRNA (lane 2), and 1 5  ug of wild type unlabeled 
probe RNA (lane 7) were incubated with the cell lysate prior to the 
addition of the radio labeled probe. 
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demonstrate that viral proteins of approximately 55 and 22 kDa mol. wt. bind to 
wt and mutant forms of stem-loop III in which stem-loop III structure is 
maintained (except in one case), in the positive strand in a higher-order-dependent 
manner. The 5 5 kDa protein, furthermore, was shown to be the viral N protein in 
an antibody-dependent electrophoretic mobility supershift assay. Cellular 
proteins of 6 1 ,  48, 45, 42, 36, and 33 kDa mol. wt. also bound to the positive­
strand probes but in a higher-order-independent manner. In the negative strand, 
seven cellular proteins of approximately 76, 66, 48, 45, 4 1 ,  33  and 25 kDa mol. 
wt. bound in a higher-order-dependent manner suggesting that this binding too 
may be part of the mechanism of action of stem-loop III . 
With the exception of viral N, the identity of the binding viral and cellular 
proteins is unknown, nor is it known whether the species identified represent 
wholly intact molecules or disassembled components of larger proteins. Certainly 
disulfide-linked multimeric polypeptides have been separated by the reducing 
conditions of the SOS-PAGE. It is quite possible that the 55 kDa cellular protein 
found earlier to bind positive-strand RNA in a region that includes stem-loop III 
in the MHV -JHM genome, and the 3 8 and 3 5 kDa proteins found to bind the 
complement of this region (Furuya et al. ,  1 993), are among the cellular proteins 
identified here. We conclude from our study, however, the 39 kDa poly(C)­
binding protein 2 and the 4 7 kDa La cellular protein are not among those that bind 
either the positive, or the negative (data not shown) strand of stem-loop III. 
How does stem-loop III in BCoV DI RNA function mechanistically in 
replication? The most straight-forward and simplest answer might be that it 
functions as a packaging signal for the DI RNA. We use as one criterion of 
replication, after-all, the presence of the higher-order mutant DI RNA in cells that 
had been delivered by infectious virus (i.e., VPl ). Although we cannot rigorously 
rule out the packaging explanation, we think it unlikely since we also use as 
criteria the measurement of how abundantly the mutated DI RNAs accumulate 
prior to packaging, and in no case did we see abundant accumulation with 
accompanying absence in VPl RNA. 
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Since previous studies using BCoV DI RNA had indicated ORF (open 
reading frame) 1 a is translated by ribosomal scanning from the 5' end of the 
genome (Senanayake et al ., 1 999), we propose that secondary structures in the 5' 
UTR do not function as part of an internal ribosomal entry site (IRES) but rather 
as structures enabling RNA synthesis. Conceivably, this might happen by stem­
loop III, probably along with stem-loop IV (Chapter IV), forming a structure 
around which an RNA replication complex would form. Since the integrity of 
stem III is required in both the positive and negative RNA strands for DI RNA 
replication (Fig. 3.1 ), we further propose that stem-loop III is important in two 
steps required for RNA replication, first in the initiation of negative-strand 
synthesis and second in the initiation of positive-strand synthesis. With regard to 
the initiation of negative-strand synthesis, we envision that stem-loop III (together 
with stem-loop IV) in the positive strand functions as a cis-acting element for the 
initiation of negative-strand synthesis through a mechanism that involves physical 
interaction of the 5' and 3' ends of the DI RNA. This aspect of the mechanism is 
no different from that proposed for other plus-strand RNA viruses wherein 
physical interactions between the genomic 5' and 3' ends leading to cyclization of 
the genome have been documented. In the case of bacteriophage Q beta (Klovins 
et al., 1 998; Klovins et al., 1 999) and the an�mal flaviviruses (Khromykh et al., 
200 1 ;  Corver et al., 2003; You et al., 1 999; You et al., 2001 )  the cyclization 
results from direct interaction of RNA elements. In the case of picomaviruses 
(Barton et al ., 2001 ; Herold et al . ,  2001 ) and alphaviruses (Frolov et al . , 200 1 ), it 
is one mediated by protein bridges. 
The model for coronavirus RNA replication as we propose it (Fig. 3.1 0) 
has the following features: (i) It explains how genome usage for viral translation, 
viral negative-strand RNA synthesis and viral positive-strand RNA synthesis is 
coordinated. (ii) The initial viral translation step of the 5' most ORF that codes for 
the viral polymerase and a variety of peptides is proposed to be initiated by the 
circularization of the capped and polyadenylated viral genome through the 7mG­
eIF 4E (eukaryotic initiation factor 4E) - eIF4G (eukaryotic initiation factor 4G)-
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Fig. 3 .10. Model for coronavirus RNA replication. A. The circular RNP 
complex for initiation of translation is proposed to be made up of the 5' cap, 
eIF4E, eIF4G, poly[A] binding protein (PABP), poly[A] tail interaction. B. The 
interaction of the 5' and 3 '  ends of the positive-strand genome to form a circular 
RNP complex that is proposed to be required for initiation of negative-strand 
synthesis is mediated by a protein bridge formed by the N protein and the 22 kDa 
viral protein (V.P) interacting with stem-loop III, the cellular proteins (C.Ps) that 
interact specifically with stem-loop IV, the PABP, and probably proteins 
interacting with the 3 '  end of the genome. This circular RNP complex probably 
forms a structure around which the replication complex forms. It probably also 
positions the RdRp at the 3 '  end of the genome for negative-strand initiation. C. 
The cellular proteins interacting with stem-loop III in the negative-strand 
probably form part of the replication complex for initiation of positive-strand 
synthesis by interacting either directly or indirectly with the RdRp. Stem-loops I 
(nts 5 to 37), II (nts 51 to 84) (Chang et al. , 1994), III (nts 97 to 116) (Chapter II), 
and IV (Chapter IV) in the 5' UTR, and the bulged stem-loop (Hsue et al., 1997) 
and pseudo knot (Williams et al. , 1999) in the 3' UTR are shown. The arrow 
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PABP (poly[A] binding protein)- poly[A] tail interaction (Fig. 3.10 A). This 
method of cyclization has been thought to be a key structural requirement for the 
initiation of translation of most eukaryotic cellular mRNAs (Gallie, 1998; Gallie, 
2002; lmataka et al. , 1998; Wells et al. , 1998). (iii) Viral negative-strand RN A 
synthesis is proposed to be initiated by a circularization mechanism in which the 
interaction of the 5' and 3' ends of the genome is mediated by a protein bridge 
comprised of the 50 kDa N protein and the 22 kDa viral or virally induced or 
modified cellular protein binding to stem-loop III, the eight cellular proteins 
binding specifically to stem-loop IV (Chapter IV), the poly[A] binding protein 
(P ABP) binding to the poly[ A] tail (Spagnolo et al. , 2000), and possibly the N 
protein binding to the leader region (Nelson et al., 2000; Stohlman et al. , 1988), 
and other proteins that bind to the 3' end of the genome (Fig. 3.10 B). This 
circular ribonucleoprotein (RNP) complex probably acts as a nucleation site for 
formation of the replication complex that includes the RNA-dependent RNA 
polymerase (RdRp) and the helicase. The circular RNP complex may also help in 
proper positioning of the RdRp and helicase at the 3' end of the genome where 
initiation of negative-strand synthesis takes place. In addition to forming a part of 
the circular RNP complex, the N protein might directly interact with the helicase, 
an interaction that was proposed based on co-immunoprecipitation assays 
(Denison et al. ,  1999). Since viral negative-strand RNA synthesis begins before 
the N protein is synthesized from its subgenomic mRNA, we propose that 
probably sufficient N protein is present in the infecting virion for formation of the 
negative-strand initiation complex. On the other hand, when naked coronavirus 
genome is used for infection, a situation in which N is not present, what would be 
the source of N? In order for the presence of N protein to precede the initiation of 
negative-strand synthesis it would have to be synthesized by translation of the N 
ORF of the virus genome by internal entry of ribosomes, a mechanism that is 
proposed to occur (Senanayake and Brian, unpublished). (iv) For initiation of 
viral positive-strand RNA synthesis, the RdRp is proposed to be correctly 
positioned at the 3' end of the negative-strand viral RN A through its interactions 
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either directly or indirectly with the seven cellular proteins that interact with stem­
loop III in the negative strand (Fig. 3.1 0 C). (v) Thus we propose that employing 
of different mechanisms for initiation of translation, negative-strand synthesis, 
and positive-strand synthesis regulates the usage of the viral genome. 
Further studies directed toward testing of this model, and also 
identification of the 22 kDa viral or virally induced or modified cellular protein 
binding to positive-strand stem-loop III and the seven proteins binding to 
negative-strand stem-loop III in a higher-order-dependent manner should provide 
insight into how the various RNA and protein elements, including stem-loop III 
function in DI RNA replication. 
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CHAPTER IV. STEM-LOOP IV IN THE 5' UNTRANSLATED 
REGION IS A CIS-ACTING ELEMENT IN BOVINE 
CORONA VIRUS DI RNA REPLICATION. 
INTRODUCTION 
Higher-order RNA structural elements in the 5' and 3' untranslated 
regions of positive-strand RNA virus genomes are known in many cases to 
function as cis-acting elements in genome translation, replication and 
transcription. The characterized mechanistic involvement of these structures in 
the 5' UTR has included (i) regulation of translation responsible for both 
downstream cis- and trans-acting factors in replication (Bink et al. , 2003; Blyn et 
al. , 1 997; Fletcher et al. , 2002; Pestova et al. , 199 1 ;  Yu et al. , 2000; and 
references therein), (ii) the binding of viral or cellular proteins to carry out 
necessary replication functions, including circularization of the virus genome 
(Andino et al. , 1 990; Barton et al. , 2001 ; Frolov et al. , 200 1 ;  Gamarnik et al. , 
1 997; Gamarnik et al. , 1 998; Herold et al. , 200 1 ;  Sizova et al. , 1998), (iii) a direct 
interaction with other RNA structural elements, including 3'-terminal structures, 
to fulfill requirements for replication (Corver et al. , 2003; Khromykh et al. , 200 1 ;  
Klovins et al. , 1 998; Klovins et al. , 1999; You et al. , 1999; You et al. , 200 1 ), and 
(iv) promoter function on the (complementary) negative-strand RNA for initiation 
of plus-strand synthesis (Yu et al. , 2000). The mechanistic features of many 
higher-order 5' UTR cis-acting elements remain to be characterized. 
In BCoV, four RNA stem-loops mapping mostly within the 21 0-nt 5'UTR 
have been predicted and, of these, stem-loops I and II have been shown to lie in a 
region of the 5' UTR (nts 1 -84) required for DI RNA replication but do not appear 
to have higher-order counterparts in other coronavirus genomes (Chang et al. , 
1 994 ). Stem-loop III shows phylogenetic conservation and a cis-acting function 
in DI RNA replication (Chapter II; Raman et al. , 2003). Experimental evidence 
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indicates both viral and cellular protein binding may play a role in the function of 
stem-loop III (Chapter III). 
Here, we characterize the higher-order structure, analyze the potential 
phylogenetic conservation, and test for the function in DI RNA replication of a 
predicted stem-loop IV. In addition, we investigate by electrophoretic mobility 
shift and UV cross-linking assays the potential binding of viral and cellular 
proteins to stem-loop IV. 
MATERIALS AND METHODS 
Virus and Cells. A DI RNA-free stock of the Mebus strain of BCoV at 4.5 
X 1 08 PFU/ml was prepared and used as a helper virus as previously described 
(Chang et al. , 1 994; Raman et al. , 2003). The human rectal tumor cell line HRT-
1 8  (Tompkins et al. , 1 974) was used as previously described (Chang et al. , 1 994; 
Raman et al. , 2003). 
Plasmid constructs. Construction of pGEM3Zf(-) (Promega)-based pDrep 
1 has been previously described (Chang et al. , 1 994). To construct the plasmid 
derivatives of pDrep 1 used in this study (Table 4. 1 ), overlap PCR mutagenesis 
(Horton et al. , 1 990) was done using the oligonucleotides listed in Table 4.2. The 
strategy for constructing each of the derivatives was the same as that used for 
constructing pSLIV-mutR except for the differences noted. For making pSLIV­
mutR, primers SR673(+), SRST6R2MUT(-), and pDrepl DNA were used in the 
first PCR, primers SRST6R2MUT(+), Forward(-), and pDrepl DNA were used in 
the second reaction, and primers Forward(-) and SR673(+) and the products of the 
first two reactions were used in the third reaction to make a 71 0-nt product that 
was trimmed to 442 nts with restriction endonucleases Hpa I and Xba I and 
cloned into Hpa I/Xba I-linearized pDrepl. For making pSLIV-mutL, 
SRST6MUT(-) replaced SRST6R2MUT(-) in the first reaction, and 




Table 4. 1 .  S f looo IV mutant -
Mutant Sequence in stem-loop IV mutant 




















Stem is disrupted. 
Stern is disrupted. 
Stem is re-formed. 
Stem-loop retained 
in (-) but 
destabilized in ( +) 
strand. 
Stem-loop retained 
in (+) but 
destabilized in (-) 
strand. 
kcal/ kcal/ Repli- Number 
mole mole cationb of UV-
in (+) in (-) cross-
strand8 strand8 linked 
protein 
bands 
-9.8 -6.7 yes 11 
no no no 3 
struct. struct. 
no no no 3 
struct. struct. 
no no no 3 
struct. struct. 
-9.8  -6.7 yes 11 
- 1 .0 -5. 1 no 3 
-6.7 - 1 .2 yes 1 1  
Table 4. 1 .  Continued. 
Mutant Sequence in stem-loop IV mutant Property of kcal/ kcal/ Repli- Number 
name (nts 186-2 15) stem-loop IV mole mole cationb of UV-
mutant in (+) in (-) cross-
strand8 strand8 linked 
protein 
bands 
pSLIV- -GGCAGUGGCCCA�CCAUAGGUCACAAUGUC- C3 in loop -9.8 -6.7 yes 1 1  
mutC198del deleted 
pSLIV- -GGCAGUGGCCCACuuAUAGGUCACAAUGUC- C4 and C5 in -9.8 -6.7 no 3 
mut7 loop changed 
to U's 
a. In some cases, no structure was predicted by the Zuker algorithm and this is indicated. 
b. Said to be replicating if there was accumulation at 24 and 48 h post transfection and the mutant form is present in cells infected 
� with VP 1 following transfection. 
Table 4.2. 01" leotid d in Ch IV 
Oli2onucleotide8 Polarity Sequence (5'->3'l Binding region in pDrepl 
Hpal (+) - GGCTGAAAGCTGTTAACAGCAGAAATG 140- 1 66 
Hpal (-) + CATTTCTGCTGTTAACAGCTTTCAGCC 140- 1 66 
Nde l (+) - CCTCCAAATCATATGGACGTGTATTC 456-481  
GEM3Zf(-)Nde 1 (-) + GAGAGTGCACCATATGCGGTGT 2498-25 1 9c 
Forward(-) + TAATACGACTCACTATA 3 1 83-3200c 
SRST6R2MUT(-) + GTGGCCCACCCATAccggtCAATGTCGAAGATC 1 90-222 
SRST6R2MUT( +) - GATCTTCGACATTGaccggTA TGGGTGGGCCAC 1 90-222 
SRDM(+) - GTTGATCTTCGACATTGTGACC 204-225 
SR673(+) - CAAGAATAGTAGGGTACAAC 673-692 
SRST6MUT(-) + GT A TCCT AGGCAGactggCACCCAT AGGTC 1 78-207 
SRST6MUT(+) - GACCT A TGGGTGccagtCTGCCT AGGAT AC 1 78-207 
SRST6DOUBLE(-) + GactggCACCCAT AccggtCAATGTCGAAGA TC 1 90-222 
SRST6DOUBLE( +) - GATCTTCGACTTGaccggT ATGGGTGccagtC 1 90-222 
SRleader(-) + GATTGTGAGCGATTTGCGTGCGTGC 1 -25 
Nonly(+) - CCAGAACGATTTCCAAAGGACGCTCT 532-557 
SR25 1 (+) - CATCCATGGAAATTCTGGAG 25 1 -270 
SR280(+) - CGTCCTCAAACATCCATGGAAATTCTGGAG 25 1 -280 
SR5 'UTR(-) + CATCCACTCCCTGTATTCTATGC 8 1 - 1 03 
SRC198(-) + CCTAGGCAGTGGCCCACCATAGGTCACAATG 1 82-2 1 3  
SRC198(+) - CATTGTGACCTATGGTGGGCCACTGCCTAGG 1 82-2 1 3  
SRL6MUT(-) + CCTAGGCAGTGGCCCACttATAGGTCACAATG 1 82-2 1 3  
SRL6MUT(+) - CATTGTGACCTATaaGTGGGCCACTGCCTAGG 1 82-2 1 3  
SRST4CA(-) + CGTGTTGTATCCTAGGCAGcaGCCCACCCATAGGTC 1 72-207 
SRST4CA(+) - GACCT A TGGGTGGGCtgCTGCCT AGGAT A CAA CA CG 1 72-207 
SRG208DEL(-) + CGTGTTGTATCCTAGTCACAATGTCGAAGATC 1 72-222 
Table 4.2. Continued. 
Oligonucleotide8 Polarity Sequence (5'->3't Binding 
region in 
pDrepl 
SRST4GU(-) + GGCAGTGGCCCACCCATAGGTtgCAATGTCGAAGATCAACAAATACGGTC 1 86-235 
SRST4GU(+) - GACCGTATTTGTTGATCTTCGACATTGcaACCTATGGGTGGGCCACTGCC 1 86-235 . 
SRG208DEL( +) - GATCTTCGACATTGTGACTAGGATACAACACG 1 72-222 
SRECOR5(-) + GTGAA TTGT AA T ACGACTCACT AT AGATatcGAGCGA TTTGCGTGCGTGC 3 1 75c-25 
SRECOR5(+) - GCACGCACGCAAATCGCTCgmATCTATAGTGAGTCGTATTACAATTCAC 3 1 75c-25 
TGEV8(+) - CATGGCACCATCCTTGGCAACCCAGA 1 098- 1 1 23 
TGEV8b(+) - CATGGCACCATCCTTGGCA 1 1 05- 1 1 23 
a. The positive and negative symbols in the oligonucleotide names indicate the polarity of the nucleic acid to which the 
oligonucleotide anneals. 
00 b. Lowercase bases represent mutated sites. 
N 
c. Indicates nucleotide positions in the pGEM3Zf(-) vector. 
pSLIV-mutL/R, SRST6DOUBLE(-) replaced SRST6R2MUT(-) and pSLIV-mutL 
DNA replaced pDrepl DNA in the first reaction, and SRST6DOUBLE(+) 
replaced SRST6R2MUT( +) and pSLIV-mutL DNA replaced pDrep 1 DNA in the 
second reaction. For making pSLIV-mutGU, SRST4GU(-) replaced 
SRST6R2MUT(-) in the first reaction and SRST4GU(+) replaced 
SRST6R2MUT(+) in the second reaction. For making pSLIV-mutCA, 
SRST4CA(-) replaced SRST6R2MUT(-) in the first reaction, and SRST4CA(+) 
replaced SRST6R2MUT(+) in the second reaction. For making pSLIV-
mutC 1 98del, SRC 1 98(-) replaced SRST6R2MUT(-) in the first reaction, and 
SRC I 98(+) replaced SRST6R2MUT{+) in the second reaction. For making 
pSLIV-mut7, SRL6MUT(-) replaced SRST6R2MUT(-) in the first reaction and 
SRL6MUT(+) replaced SRST6R2MUT(+) in the second reaction. pSLIV-mutDel 
was made in a two-step procedure as follows: (i) pSM3del was made by digesting 
pSM3 (pDrep 1 with a G inserted at position 208 to create a Sal I restriction 
enzyme site [Chang et al. , 1 996]) with Avr II (which cuts at nt 1 83) and Sal I 
(which cuts at nt 205), filling in with Kienow enzyme and ligating (thus removing 
the stem-loop IV-containing 1 86nt to 205nt fragment). (ii) 0208 was removed 
from pSM3del by PCR mutagenesis to create pSLIV-mutDel. For this, the steps 
as described above for synthesis of pSLIV -mutR were used except that 
SRG208DEL(-) replaced SRST6R2MUT(-) and pSM3del DNA replaced pDrep 1 
DNA in the first reaction, and SRG208DEL( +) replaced SRST6R2MUT( +) and 
pSM3del DNA replaced pDrep 1 DNA in the second reaction. 
For making pSLIV(PB), identical to pDrepl except nts 4 through 1 52 are 
missing thus enabling synthesis of 1 1 3-nt stem-loop IV-containing probes for 
testing protein binding, a two step procedure was used: (i) An EcoR V restriction 
endonuclease site was created at nt 3 in pDrep 1 by overlap PCR mutagenesis in 
which Nde l (+), SRECOR5(-) and pDrepl DNA were used in the first reaction, 
SRECOR5(+) and GEM3Zf(-)Nde l (-) and pDrep l DNA were used in the second 
reaction, and GEM3Zf(-)Nde l (-) and Nde l (+) and the products of the first two 
reactions were used in a third reaction to make a 1 1 83-nt product that was 
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trimmed to 69J nts with restriction endonucleases NgoM IV and Avr II and 
cloned into NgoM IV/Avr II-linearized pDrep l .  (ii) The resulting plasmid was 
digested with EcoR V and Hpa I to remove nts 4 through 152 and the ends of the 
remaining fragment were ligated. The strategy used for making pSLIV -
mutDel(PB) was the same as that for making pSLIV(PB) except that (i) pSLIV­
mutDel DNA was used instead of pDrep l DNA, (ii) the 1163-nt product from the 
third PCR reaction was trimmed to 663 nts with restriction endonucleases N goM 
IV and Hpa I, and (iii) the product was cloned into NgoM IV/Hpa I-linearized 
pSLIV -mutDel DNA. 
For making pSLIV-mutR(PB), pSLIV-mutL(PB), pSLIV-mutL/R(PB), 
pSLIV-mutC l 98del(PB), pSLIV-mut7(PB), pSLIV-mutGU(PB), and pSLIV­
mutCA(PB), pSLIV(PB) was digested with NgoM IV and Avr II and the 545 nt 
fragment was cloned into the respective NgoM IV/Avr II-linearized mutant 
plasmids pSLIV-mutR, pSLIV-mutL, pSLIV -mutL/R, pSLIV-mutC l 98del, 
pSLIV -mut7, pSLIV-mutGU, and pSLIV-mutCA. 
Enzyme structure probing of RNA. . Enzyme structure probing was 
carried out as previously described (Chapter II) except that primer extension 
reactions on RNase-digested RNA were done with 5' -end-labeled plus-strand­
binding oligonucleotide SR280(+) (Table 4.2; Fig. 4.1). Undigested RNA was 
used with the same primer in dideoxynucleotidyl sequencing reactions to generate 
a sequence marker. 
Northern assay for DI RNA replication. The Northern assay was 
performed as previously described (Chapters II and III). 
Sequence analysis of the stem-loop IV region in progeny DI RNAs. For 
direct sequencing of asymmetrically-amplified cDNA, the procedure as described 
by Hofmann et al (Hofmann et al. , 1993) for analysis of plus-strand RNA was 
used. Briefly, oligonucleotides TGEV8b( +) and SRleader(-) (Table 4.2) were 
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Fig. 4. 1 .  Phylogenetic and enzyme structure probing evi9ence for stem-loop IV 
in BCoV genomic RNA. A. Predicted secondary structures within the 2 1 0-nt 5' 
UTR of the BCoV genome and the site from which the 5' end-labeled primer was 
extended for stem-loop IV structure determination. The 65-nt BCo V leader 
sequence is shaded and the leader-associated UCUAAAC intergenic sequence 
(nts 64-70, identified in bold) is found within loop II. The start and stop codons 
for the stem-loop III associated intra-5' UTR ORF and the start codon for ORF la 
are boxed. Previously described stem-loops I, II and III are identified. Stem-loop 
IV is shown along with the variant bases found among the eight sequenced 
members of group 2 coronaviruses (see text). Bases with no superscript are found 
in all MHV strains (A59, 2, JHM); superscript identity: e, equine coronavirus; h, 
HCoV-OC43. Stem-loop IV is identical in BCoV, HEV, and HECoV. B. 
Enzyme probing data for stem-loop IV. Depicted is a DNA sequencing gel 
showing separation of primer extension products. RNase digestion conditions for 
the double strand-digesting CVl and single strand-digesting RNase T2 are 
described in the text. Lanes 2 to 5 show the products of an RNA sequencing 
reaction done on undigested RNA to identify the base positions. C. Summary of 
enzyme probing data shown in part B. 
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used for RT-PCR with RNA extracted at 48 hpi from cells infected with the first 
passage virus (VP 1 ), and in some cases second passage virus (VP2), and 5 'end­
radiolabeled oligonucleotide Hpal (-), SRDM(+), SR25 1 (+), or SR280(+) was 
used for sequencing. 
Protein binding assays. Preparation of cell lysates and the electrophoretic 
mobility shift assays (EMSAs) essentially followed the procedures of Gamarnik 
and Andino (Andino et al. , 1 990; Gamarnik et al. , 1997). The method of probe 
elution from preparative gels was that of Thomson et al (Thomson et al. , 1999). 
Cell lysates in 10 ul aliquots containing 20 ug total protein each were prepared at 
6 h postinfection, or post-mock infection, as previously described (Chapter III). 
For synthesis of the radiolabeled RNA probes for EMSAs and protein 
crosslinking analyses, wt stem-loop IV-containing pSLIV(PB) and the (PB) 
modifications of the stem-loop IV mutants (Table 4. 1 )  were linearized with 
restriction endonuclease Nco I and transcribed with T7 RNA polymerase in a 50 
ul reaction volume containing 1 20 uCi a32P-UTP (300 Ci/mmol). Transcripts 
were 1 1 3 nts in length from all constructs except pSLIV-mutdel(PB) which were 
93 nts. Radiolabeled transcripts were purified by electrophoresis on an 8 M 
urea/6% polyacrylamide gel (Andino et al. , 1 990; Thomson et al. , 1 999) and 
unlabeled transcripts used as competitor RNA were purified by chromatography 
through a Biospin 6 column (BioRad). 
EMSAs were carried out as described elsewhere (Chapter III). For the 
supershift assays, 2 ul of antiserum ( containing approximately 40 ug of protein 
total) was added to the reaction mixture in one set before and in another set after 
the RNA-protein binding reaction was complete and the mixture was incubated on 
ice for 30 minutes prior to electrophoretic separation (Andino et al. , 1 990; 
Gutierrez-Escolano et al. , 2000). Rabbit polyclonal anti PCBP-2 and preimmune 
sera (Blyn et al. , 1 997) were kind gifts from E. Ehrenfeld (U. C. Irvine) and 
mouse polyclonal anti-La antiserum was obtained from BD Biosciences. 
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UV cross-linking and molecular weight determinations of RNA binding 
proteins by SDS PAGE on gels of 10% polyacrylamide were carried out as 
previously described (Chapter Ill). 
Synthetic oligonucleotides and accession numbers. Oligonucleotides used 
in this study are described in Table 4.2. GenBank accession numbers for the 
sequences studied are U00735 for BCo V-Mebus, AF523843 for HCo V-OC43, 
AF523844 for HECoV-4408, AF523845 for HEV-TNl 1 ,  AF523846 for ECoV­
NC99, AF201 929 for MHV-2, NC001 846 for MHV-A59, M55148 for MHV­
JHM, 234093 for TGEV-Purdue 1 1 6, 6972 1 for HCoV-229E, NC 00 1451  for 
IBV-Beaudette, and AY27874 1 for HCoV-SARS. 
RESULTS 
A predicted stem-loop IV in the BCoV 5' UTR shows phylogenetic 
conservation among group 2 coronaviruses. Analysis of the 2 10  nt 5' UTR and 
flanking sequences of the BCoV genome for RNA secondary structures using the 
mfold program of Zuker ( <http:/ /bioinfo.math.rpi.edu/~zukerm/>, Mathews et al. , 
1999; Zuker et al. , 1 999) pr�dicted the existence of a potential stem-loop with a 
stem of ten base pairs containing an internal loop of 2 nts, a terminal loop of 8 nts, 
and a free energy value of -9.8 kcal/mole (Fig. 4. 1 A). In the negative strand, a 
bulged stem-loop with a terminal tetraloop and a free energy of -6.7 kcal/mole 
was also predicted (Fig. 4.2). 
The 5' UTR sequences for 1 2  coronaviruses species including the SARS 
corona virus have now been reported enabling comparisons of predicted higher­
order structures (see references described in GenBank accession numbers given 
above). For. the eight members in group 2, BCoV-Mebus, HCoV-OC43, HECoV-
4408, HEV-67N, ECoV-NC99, MHV-2, MHV-A59, and MHV-JHM, the mfold 
program predicted a stem-loop IV with small variations (stem-loop IV is identical 
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Fig. 4.2. Stem-loop IV-deleted DI RNA does not accumulate in 
helper virus-infected cells. The mfold-predicted structures of wt 
(pDrep 1 )  and mutant (pSLIV-mutDel) transcripts in the positive 
and negative strands and their calculated free energies in 
kcal/mole are shown. Deleted bases in pSLIV-mutDel are 
represented by A. Accumulation was measured by Northern 
analysis with a reporter-specific radiolabeled oligonucleotide. For 
Northern analyses, T7 RNA polymerase-generated transcripts of 
linearized plasmids were transfected into BCo V-infected cells and 
RN A was extracted at the indicated times post transfection and at 
48 h postinfection with virus passage 1 (VP 1 ). Accumulation of 
pDrep 1 progeny was considered to be 100%. The sequence of the 
RNA in VPl progeny replicons was determined by bulk RT-PCR 
sequencing using pDrep I -specific primers as described in the text. 
Lanes: Uninf., mock infected, non-transfected cells; Inf., infected, 
non-transfected cells; RNA, sample of the transcript. 
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(Fig.4. l Af A possible analog if not homolog is also found in coronavirus groups 
1 and 3 and in the SARS coronavirus (see Discussion). The predicted stem-loop 
IV for group 2 coronaviruses (i) has a stem of ten base pairs with either a two nt 
internal loop as in BCoV, HCoV, HECoV, HEV and ECoV, or a four nt internal 
loop as in MHV-2, MHV-A59 and MHV-JHM with net negative free energies 
ranging from - 12  to -9.8 kcal/mole, (ii) has an 8-nt terminal loop whose sequence 
is identical in BCoV, HECoV, HEV, MHV-2, MHV-A59 and MHV-JHM, and 
differs by one base at nt position 1 97 in HCoV and ECoV, (iii) has a negative­
strand counterpart with net negative free energies ranging from -8 .9 to -6.7 
kcal/mole, (iv) begins at base 1 83 for MHV-2 and MHV-A59, 1 85 for ECoV, 1 86 
for BCoV, HCoV, HECoV and HEV, and 1 88 for MHV-JHM. 
Thus, since a predicted stem-loop IV showed phylogenetic conservation in 
all group 2 coronaviruses it was postulated to be a higher-order cis-acting element 
in BCoV DI RNA replication. 
Enzyme structure probing supports existence of stem-loop IV in BCo V 
RNA. An in vitro-transcribed 595-nt transcript of Xba I-linearized pDrep 1 DNA 
was digested with either single strand-specific RNases Tl (data not shown) or T2, 
or with double strand-specific RNase CVl ,  and the products were analyzed by 
reverse transcriptase extensions of the 5' end-labeled primer SR280(+) (Fig. 4. 1 
B, lanes 1 1 -1 5 and 6-10). Radio labeled products of an RNA sequencing reaction 
were analyzed in parallel to determine the sites of RNase digestion (Fig. 4. 1 B, 
lanes 2-5). Enzyme probing indicated that the upper part of the stem (nts 1 90 to 
1 95 and 204 to 209) is susceptible to digestion by only RNase CVl and is 
therefore probably stably base-paired whereas the lower part of the stem (nts 1 86 
to 1 89 and 2 12  to 2 1 5) appear susceptible to both RNases CVl and T2 and might 
represent a breathing structure in which a base-paired state alternates with a single 
stranded region. The predicted loop of stem-loop IV, on the other hand, is 
strongly digested by RNase T2 and is therefore likely to be a single-stranded 
region, consistent with it being a loop as predicted. The results of enzyme 
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structure probing overall show single- and double-strand regions in agreement 
with an m/o/d-predicted structure for stem-loop IV (Fig. 4. 1 C). 
Integrity of stem IV is required for BCo V DI RNA replication. The 
rationale applied here for evaluating the functional importance of an RNA 
element in DI RNA replication has been previously described (Chapters II and 
III). Briefly, an element was deemed required if its removal or structural 
disruption by mutation led to a loss of DI RNA accumulation at 24 h and 48 h 
post transfection and an absence of mutated progeny molecules in VPl RNA. In 
the case of a disrupted helical region, if restoration of the stem by compensatory 
mutations leads to restored replication at 24 h and 48 h post transfection and the 
presence of the double mutant progeny in VPl RNA then the stem is deemed a 
required element. In an initial test to examine the requirement of stem-loop IV in 
DI RNA replication, mutant pSLIV-mutDel was made and tested in which almost 
the entire stem-loop was deleted (Table 4. 1 ,  Fig. 4.2). By Northern analysis, 7% 
and 1%  of wt levels of DI RNA had accumulated by 24 and 48 hpt, respectively, 
and less than 1 % had accumulated by 48 hpi in VP 1 .  Sequence analysis of 
asymmetrically amplified cDNA fr?m VPl DI RNA, however, showed all 
progeny to be wild type and hence revertants, indicating the deletion mutant had 
not replicated and thus stem-loop IV is probably necessary for replication. 
To examine the importance of the helical nature of stem IV in DI RNA 
replication, mutant pSLIV-mutL and pSLIV-mutR were made in which five of the 
six base pairs in the upper helix were disrupted in the left and right arms, 
respectively, leading to no predicted stem IV structure in either the positive or 
negative strands (Table 4 . 1 ,  Fig. 4.3). By Northern analysis, 10% or less of wt 
levels of DI RNA had accumulated by 24 and 48 hpt and less than 1 % by 48 hpi 
in VPl .  Sequence analysis of asymmetrically amplified cDNA made from VPl 
DI RNA showed the progeny of both mutants to be wt indicating they had not 
replicated. By contrast, accumulation of progeny from the double mutant pSLIV -
mutL/R in which stem IV had been restored was 243% of wt levels at 24 hpt, 95% 
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Fig. 4 .3. Integrity of stem IV is required for DI RNA 
replication as determined by analysis of mutant variants 
of pDrepl . Mutated bases are shown as lowercase 
letters. The assays were carried out as described in Fig. 
4.2. 
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at 48 hpt, and 28% in VPl (Fig. 4.3). Asymmetrically amplified cDNAs from 
VPl and VP2 DI RNA (not shown) showed progeny to have retained the double 
set of mutations. These results, therefore, indicate that the helical region of stem­
loop IV either in the positive or negative strand, or both, is required for DI RNA 
replication. A lower rate of accumulation in the double mutant than in wt at VP 1 
suggested factors other than the helical nature of the stem, possibly the nucleotide 
sequence within the stem, might also be important for maximal accumulation. 
Integrity of stem IV in the positive but not the negative strand is required 
for BCoV DI RNA replication. Base pair covariations among group 2 
coronaviruses maintain a stable stem-loop IV in both the positive (free energy 
range, - 1 2  to -9.8  kcal/mole) and negative (free energy range, -8.9 to -6.7 
kcal/mole) strands. The question of which strand stem-loop IV functions was not 
answered by the stem IV disruption experiment described above since the helical 
region had been disrupted simultaneously in both strands in the two non­
replicating mutants, and wt net negative free energy values in both had been 
restored in the replicating double mutant (Table 4. 1 ). Therefore, to test the strand 
requirement for stem-loop IV, mutations in pDrep 1 were made such that either the 
positive or negative strand was destabilized and transcripts were tested for 
replication. For mutant pSLIV-mutGU, in which stem-loop IV was destabilized 
in the negative but not positive strand (Table 4. 1 ), Northern analysis showed 
220% of wt levels at 24 hpt, 1 32% at 48 hpt, and 1 1 4% in VPl ,  and sequence 
analysis of asymmetrically-amplified cDNAs showed all progeny in VP 1 to be 
mutant sequence thus indicating transcripts of pSLIV-mutGU had replicated (Fig. 
4 .4). By contrast, for mutant pSLIV-mutCA in which stem-loop IV had been 
destabilized in the positive but not negative strand, Northern analysis showed an 
accumulation of 1 9% of wt levels at 24 hpt, 1 5% at 48 hpt and 1 7% in VP 1 ,  and 
sequence analysis showed all progeny from VP 1 to be wt molecules indicating the 
mutant had not replicated .(Fig. 4.4). Taken together these results indicate that the 
integrity of stem-loop IV for DI RNA replication is required in the positive but 
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Fig. 4.4. Integrity of stem IV in the positive strand but 
not in the negative strand is required for DI RNA 
replication. This is determined by analysis of mutant 
variants of pDrep 1 .  The assays were carried out as 
described in Fig. 4.2. 
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not the negative strand and that minor changes in stem sequence at least in the 
mutated positions do not affect replication. 
At least some aspects of wild type loop IV sequence are necessary for 
BCoV DI RNA replication. The phylogenetic conservation of loop IV length and 
partial primary sequence within group 2 coronaviruses (Fig. 4.1 A) led to the 
hypothesis that loop IV plays a role in the function of stem-loop IV. In the first of 
two mutants made to test this notion, C3 in the 8-nt loop was deleted creating 
pSLIV-mutC 198del (Fig. 4.5 A). In the second, C4 and C5 in the loop were 
changed to U's creating pSLIV-mut7 (Fig. 4.5 B). The free energies of stem-loop 
IV in both constructs were identical to wt (Table 4.1 ). Although for construct 
pSLIV-mutC 198del only mutant sequences were found in VPl progeny thus 
showing replicability of the mutant molecules, accumulation was two-fold less at 
24 and six-fold less at 48 hpi (VP 1) than wt indicating wt loop length or sequence 
integrity may contribute to optimal DI RNA replication. Northern analysis of 
progeny from pSLIV-mut7, on the other hand, showed accumulation rates of less 
than 3% ofwt throughout, and sequence analyses showed only wt in VPl progeny 
indicating mutant molecules had not replicated. Taken together these results 
indicate that loop IV is an important component of the stem-loop IV cis-acting 
element required for DI RNA replication. 
Eight cellular proteins bind specifically to wild type stem-loop IV RNA 
but not to mutated nonfunctional forms. To test the hypothesis that stem-loop IV 
functions through interactions with cellular or viral proteins, plasmid pSLIV(PB) 
encoding wt stem-loop IV was linearized at the Nco I site and used to generate 
uniformly labeled 113-nt transcripts for electrophoretic mobility shift assays. On 
incubation with lysates of BCoV-infected (Fig. 4.6, lane 3) or mock-infected (lane 
4) cells, three distinct bands of lower mobility were apparent whereas no change 
in mobility was observed when probe was incubated with buffer alone (lane 1), or 
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Fig. 4.5 .  Wild type loop IV sequence correlates with maximal 
DI RNA accumulation. A. Accumulation and sequence of 
progeny from DI RNA in which loop IV is shortened from 8 to 
7 bases in length (pSLIV-mutC l 98del). The deleted base is 
represented by fl.. B. Accumulation and sequence of progeny 
from DI RNA in which the loop IV primary sequence is 
changed (pSLIV-mut7). Assays were carried out as described 
in Fig. 4.2. 
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Complex I I I  C 
Complex II C 
Complex I C 
Free probe [ 
competitor RNA 
S-L IV RNA tRNA 
____________, ____________, 
1 2 3 4 5 6 7 8 9 1 0  
Fig. 4.6. Cellular but not viral proteins bind specifically to stem­
loop IV-containing RNA. A uniformly labeled 1 13 nt stem-loop 
IV -containing RNA probe was used in electrophoretic mobility 
shift assays as indicated. Probe treatments: Lane 1 ,  incubated 
with buffer; lane 2, incubated with proteinase K-treated infected 
cell lysate; lane 3, incubated with infected cell lysate; lane 4, 
incubated with uninfected cell lysate; lanes 5-7, incubated with 
uninfected cell lysate to which had been added 5, 1 0, and 1 5  ug 
of unlabeled probe RNA, respectively; lanes 8- 1 0, incubated 
with uninfected cell lysate to which had been added 5, 1 0, and 
1 5  ug yeast tRNA, respectively. 
97 
(lane 2). These results indicate that all three complexes were formed at least in 
part by interactions with cellular but not viral proteins. The complexes, 
furthermore, were specific to stem-loop IV-containing RNA since addition of 
increasing amounts of unlabeled probe as competitor reduced complex formation 
in a dose dependent manner (Fig. 4.6, lanes 5 to 7) whereas addition of tRNA, a 
presumed nonspecific competitor, did not (lanes 8 to 10). These results together 
indicate that stem-loop IV-containing RNA is a binding target for cellular but not 
viral proteins. 
To determine whether the proteins are binding to the 30-nt stem-loop IV 
element, and, simultaneously, to establish whether binding is specific to the wt­
like helical structure, electrophoretic mobility shift assays were done in a way that 
compared the four functional (including wt) and five nonfunctional mutated forms 
of stem-loop IV (Table 4. 1 and Fig. 4.7). Interestingly, transcripts from all eight 
mutant constructs were shifted to form the three RNA-protein complexes similar 
to those found with wt stem-loop (Fig. 4.7). These results indicate that at least 
some cellular proteins are binding to the transcripts regardless of the replicating 
potential of the mutant. 
To determine the number and sizes of the proteins in the complexes, UV 
cross-linking between the radiolabeled RNA and proteins was done followed by 
digestion with a mixture of single strand and double strand-specific RNases and 
SDS PAGE analysis. By this analysis, eleven distinct bands representing 
approximate molecular weights of 78, 64, 58, 48, 45, 4 1 ,  39, 33 ,  28, 26, and 25 
kDa were found when wt RNA was used with lysates of uninfected (Fig. 4. 8 A, 
lane 5, . and Fig. 4.8 B, lane 8) or infected (Fig. 4.8 A, lanes 1 and 4, and Fig. 4.8 
B, lane 9) cells. This was consistent with the finding that shifting patterns were 
the same between infected and uninfected cells indicating that cellular but not 
viral proteins were binding to the stem-loop IV-containing RNA. The elimination 
of all eleven bands with proteinase K treatment (Fig. 4.8 A, lane 2, and Fig. 4.8 B, 
lane 1) established their protein identity. Additionally, all eleven cellular proteins 
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Fig. 4.7. Cellular proteins bind to both replicating and nonreplicating 
mutated forms of stem-loop IV RNA. Electrophoretic mobility shift 
assays were done with radiolabeled transcripts made from the indicated wt 
and mutant constructs. All probes were 1 1 3 nts in length except for the 
probe from pSLIV -mutDel which was 93 nts in length. In some cases, 
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Fig. 4.7. Continued. 
1 00 
Fig. 4.8. Eleven cellular proteins bind stem-loop IV RNA, but only eight bind 
specifically. UV cross-linking was done on protein binding reactions prepared as 
described in Fig. 4. 7. Reaction products were then digested simultaneously with 
RNases Tl , A and CVl , as described in the text and electrophoretically separated 
on 10% SDS-PAGE gels. Where indicated, 15 ug of competitor RNA was 
incubated with the cell lysate prior to the addition of the radio labeled probe. 
Numbers to the right indicate molecular weight positions as determined by 
molecular weight markers, and to the left indicate estimated molecular weights of 
the radiolabeled proteins. 
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bound specifically to the stem-loop IV-containing RNA since addition of 1 500-
fold excess of unlabeled transcript prevented complex formation (Fig. 4.8 A, lane 
3) whereas the same amount of yeast tRNA did not (Fig. 4.8 A, lane 4). 
Interestingly, whereas all eleven cellular proteins bound probe from wt 
(Fig. 4.8 A, lanes 1 ,  4 and 5 ,  and Fig. 4.8 B, lanes 8 and 9) and replicating mutant 
constructs (mutL/R, Fig. 4.8 B, lane 3 ;  mutGU, Fig. 4.8 A, lane 8; and 
mutCl 98del, Fig. 4.8 B, lane 4), only three cellular proteins with molecular 
weights of 48, 45 and 33 kDa bound probe from the non-replicating mutants 
(mutDel, Fig. 4.8 A, lane 7; mutL, Fig. 4.8 B, lane 6; mut R, Fig. 4.8 B, lane 5 ;  
and mut7, Fig. 4 .8  B, lane 7). These data together indicate the eight proteins with 
molecular weights of 78, 64, 58, 4 1 ,  39, 28, 26 and 25 kDa were interacting with 
stem-loop IV in a function-dependent manner and that the interaction might 
reflect a mechanistic feature of stem-loop IV function in BCo V DI RNA 
replication. 
DISCUSSION 
In this study, we have shown by enzyme structure probing the existence of 
a predicted bulged stem-loop IV mapping at nts 1 86 through 2 1 5  and therefore 
lying mostly within the 2 1 0-nt 5 '  UTR ofBCoV DI RNA. Stem-loop IV shows 
phylogenetic conservation in structure and largely also in sequence among the 
group 2 coronaviruses, and although it is predicted to exist in the minus strand as 
well, it was shown by mutation analysis in DI RNA to function in replication only 
in the positive strand. At least part of the primary sequence of loop IV was found 
to be essential for DI RN A replication. Protein binding studies, furthermore, 
demonstrated that eight cellular and no viral proteins bind specifically to wt and 
functional mutated forms of stem-loop IV but not to mutated nonfunctional forms. 
It is not currently known whether the eight cellular protein species 
represent wholly intact molecules or disassembled polypeptides of larger proteins, 
nor is the identity of any of the proteins known. The fact that the conserved loop 
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IV sequence of 5'CACCCAUA3' in group 2 coronaviruses contains the ACCCA 
motif also found in 5' ACCCACCC3', a poly(C)-protein binding sequence in the 
poliovirus genome (Gamarnik et al. , 1998; Parsley et al. , 1997), led us to test 
whether the 39 kDa poly(C)-binding protein was one of the proteins binding stem­
loop IV. An electrophoretic mobility supershift assay with antiserum to poly(C)­
binding protein, however, showed no supershifted complex indicating this protein 
is probably not one of the binding proteins (data not shown). Nor was 
supershifting observed when antiserum to the 4 7 kDa La cellular protein, a 
protein known to react with a variety of cellular and viral RN As (Yocupicio­
Monroy et al. , 2003; and references therein), was tested. To our knowledge, in no 
study has a protein been identified that binds to the region of the corona virus 
genome encompassing stem-loop IV. 
ls there a stem-loop IV equivalent in coronavirus groups 1 and 3, and in 
the SARS coronavirus? Since the corona virus genomic 5' UTRs range in length 
from 210 nts in BCo V to 528 in IBV, it is not immediately apparent what 
predicted folded structures might be analogous among them. By the arbitrary 
criteria of (i) the most probable higher-order structure predicted by the Zuker 
algorithm (i.e., the structures having the highest pnum value), (ii) distance from 
the genome 5' terminus (and hence also from stem-loop III, a predicted homolog 
found similarly positioned from the 5' end in groups 1, 2 and 3 [Chapter 11; 
Raman et al. , 2003 ]), and (iii) apparent conserved features such as loop sequence, 
we postulate likely analogs of stem-loop IV in group 1 and the SARS coronavirus, 
but a less likely analog in group 3 (Fig. 4.9). In IBV, however, a stable stem-loop 
structure with high pnum values and a structure loosely resembling the first (i.e., 
most upstream) of duplicate stem-loop structures in group I and SARS 
coronavirus, but starting at nt 325, is found (Fig. 4.9). Thus, perhaps our second 
arbitrary criterion is not applicable with such a long 5' UTR as found in IBV. In 
the group I corona viruses TG EV and PED V, and in the SARS corona virus, the 
loop of stem-loop IV is a highly conserved hexaloop (UU[U/C]CGU), and stem­
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Fig. 4.9. Potential stem-loop IV equivalent structures in coronavirus 
groups 1 and 3, and the SARS coronavirus, as predicted by the Zuker 
mfold algorithm. 
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times in PEDV with the same hexaloop sequence (Fig. 4.9). We have used the 
terms stem-loops IV-1, IV-2, and IV-3 to identify these (Fig. 4.9). In the group I 
coronavirus HCo V-229E, stem-loop IV appears two times with a nearly identical 
hexaloop sequence in one and pentaloop sequence in the other (UUCCG[U]) (Fig. 
4.9). In the group III coronavirus IBV, a stem-loop IV-like structure is predicted 
beginning at nt 325 (Fig. 4.9). The free energies of these structures, both in the 
positive and negative strands, are given in Fig. 4.9 and its legend. 
How does stem-loop IV in BCoV DI RNA function mechanistically in 
replication? Previous studies using BCoV DI RNA had indicated that ORF la is 
translated by ribosomal scanning from the 5' end of the genome (Senanayake et 
al., 1999) and thus it is unlikely that stem-loop IV is a required structure for 
directing an "intemal entry of ribosomes for the translation of ORF la. It is 
therefore proposed that stem-loop IV along with stem-loop III functions in the 
formation of the RNA replication complex. This concept is consistent with the 
observation that stem-loop IV is part of a contiguous 421-nt sequence found in the 
BCoV DI RNA but missing in subgenomic mRNA 7 that, despite being identical 
to the DI RNA replicon in every other respect, fails to replicate after transfection 
into helper virus-infected cells (Chang et al., 1994). Since the higher-order 
integrity of stem IV in only the positive RNA strand is required for replication 
(Table 4.1, Fig. 4.4)), one possibility is that it functions as a cis-acting element in 
the initiation of negative strand synthesis. This notion has precedence in the 
behavior of other plus-strand RNA viruses where physical interactions between 
the genome 5' and 3' ends are necessary for initiation of negative-strand RNA 
synthesis. In some cases as in flaviviruses the cyclization results from RNA-RNA 
interactions (Corver et al., 2003; Khromykh et al., 2001; You et al., 1999; You et 
al., 2001 ). In other cases as in poliovirus and alphaviruses, the interaction is 
through protein bridges (Barton et al. , 2001; Herold et al., 2001; Frolov et al., 
2001). In BCoV DI RNA the interaction of stem-loops III and IV with proteins 
would suggest bridging and circularization, if it occurs, would be through proteins 
(Chapter III, Fig. 3.10). 
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A positive correlation between the binding of eight cellular proteins to 
stem-loop IV and replication ability of the DI RNA suggests that stem-loop IV 
functions in replication through its interaction with these proteins. Further 
analyses to identify these proteins and determine how they interact with each 
other and with stem-loop IV should provide insight into how stem-loop IV 
functions in DI RNA replication. 
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CHAPTER V. FUTURE DIRECTIONS. 
INTRODUCTION 
With the recent interest in coronavirus research after the severe acute 
respiratory syndrome outbreak, it has become essential to better understand the 
mechanism of replication of these viruses, with a view to develop drugs and 
vaccines to combat this illness. 
In this dissertation, two phylogenetically conserved, cis-acting RNA 
secondary structural elements, stem-loops III (Chapter II) and IV (Chapter IV) 
have been identified that are required for BCoV DI RNA replication. In addition 
to this, a replication enhancer element, the stem-loop III associated 5' UTR ORF 
has been identified (Chapter II). These elements are proposed to be required for 
viral genome replication in addition to DI RNA replication, and are postulated to 
function in the formation of the viral replication complex that is made up of 
cellular and viral proteins that interact with these structures. This study opens up 
interesting future directions of research in the following aspects of coronavirus 
replication: 
TO IDENTIFY AND CHARACTERIZE THE PROTEINS THAT 
INTERACT WITH STEM-LOOPS III AND IV 
In this dissertation, stem-loop III has been proposed to function through its 
interactions with cellular and viral proteins (Chapter III), and stem-loop IV has 
been proposed to function through its interactions with cellular proteins (Chapter 
IV). The proteins interacting with these two structures could be identified by first 
purifying them using RNA affinity purification using synthetic, biotinylated RNA 
containing stem-loop III or IV bound to streptavidin beads, and the proteins could 
be identified by mass spectrometry and peptide microsequencing. The identities 
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of these proteins could then be confirmed by using electrophoretic mobility 
supershift assays using antibodies that are specific to these proteins. The precise 
binding site of these proteins on stem-loops III and IV (the exact nucleotides that 
interact with these proteins) could be mapped out using RNA footprinting assays. 
Further, the interactions of the different proteins with each other, within the 
protein complex that binds to stem-loops III and IV could be studied using co­
immunoprecipitation assays and yeast two hybrid assays. 
Towards understanding the role that each of the stem-loop binding 
proteins play, expression of each of the identified proteins could be silenced using 
siRNA (short interfering RNA), and virus replication in the absence of that 
protein could be studied and compared to virus growth in a system that is 
reconstituted with that protein. 
TO DETERMINE THE X-RAY STRUCTURE OF RNA-PROTEIN 
COMPLEXES OF STEM-LOOPS III AND IV 
The X-ray structure of the RNA-protein complex of the Rotavirus 
nonstructural protein NSP3 bound to a rotaviral mRNA 3 '  end has been 
determined (Deo et al. , 2002). Using the protocol in that study, the RNA 
containing stem-loop III or IV could be co-crystallized with the purified proteins 
that bind these RNA structures, and the RNA-protein X-ray structure could be 
determined. This study would provide valuable insights into the specificity of 
protein-RNA binding in the formation of the viral replication complex. 
TO DETERMINE THE SECONDARY STRUCTURE OF THE 
BCoV 5 '  UTR NEGATIVE-STRAND RNA 
Though both stem-loops III and IV can potentially exist in both the 
positive as well as in the negative RNA strands, only stem-loop III has been 
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proposed to function in replication in both the positive and negative strands 
(Chapter III). Stem-loop IV has been proposed to function in only the positive 
RNA (Chapter IV). The higher-order structures of both stem-loops III and IV 
have been mapped out in the positive-strand using enzyme probing assays, in this 
dissertation (Chapters II and IV). Secondary RNA structures that could 
potentially function in replication, in the 5' UTR negative-strand could be mapped 
out using the enzyme probing protocol described in this dissertation. Then, these 
structures could be selectively destroyed in the negative-strand RNA, and the 
effect of these mutations on replication could be examined. 
TO CHARACTERIZE THE ROLE OF STEM-LOOPS III AND IV 
IN NEGATIVE-STRAND RNA SYNTHESIS 
RN ase protection assays described in the appendix of this dissertation 
(Fig. A.2) hint at the possibility that stem-loops III and IV might function in 
negative-strand RNA synthesis. Non-replicating stem-loop III and IV mutants 
were shown by this assay to synthesize lower levels of negative-strand RN A than 
the wild type BCoV DI RNA. Further examination of the possibility that stem­
loops III and IV function in negative-strand RNA synthesis could be done. For 
this, the sequences of the negative RNA strands synthesized by the stem-loop III 
and IV mutants could be determined to ascertain whether these mutants maintain 
their mutant sequences during negative-strand synthesis .. Also, RNase protection 
assays for negative-strand RNA synthesis at different time points could be done. 
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A PREDICTED STEM-LOOP III ANALOG WITH AN ASSOCIATED 
SHORT ORF EXISTS IN PEDV AND IN HCoV-SARS 
Chapter II of this dissertation describes a cis-acting replication element, 
stem-loop III that maps at nts 97 through 1 16 in the BCoV 5' UTR. Stem-loop III 
in BCoV has associated with it beginning at nt 100 an AUG-initiated intra-5' 
UTR open reading frame that is proposed to function as an enhancer of 
replication. Stem-loop III and its associated ORF show phylogenetic 
conservation among all sequenced group 2 coronaviruses, group 1 coronaviruses 
TGEV and HCoV-229E, and group 3 coronavirus IBV. Though stem-loop III has 
an ORF associated with it in all corona viruses, the length and sequence of the 
oligopeptides encoded by this ORF are dissimilar. 
Mfold analysis of the 5' UTR sequences of the recently sequenced group 1 
coronavirus PEDV, and the HCo V-SARS coronavirus, indicated that a bulged 
stem-loop III analog with associated intra-5' UTR ORFs is positioned similarly 
within the 5' UTR (Fig. A. 1 ). The predicted loop III is a tetraloop in PEDV 
(loop III is a tetraloop in BCo V), and is a pentaloop in HCo V-SARS. PEDV has 
two stem-loop III associated intra-5' UTR ORFs, like in HCoV-229E. In PEDV 
these two ORFs code for peptides with sequences MFMLLEAGVEFH, and 
MLLEAGVEFH. The stem-loop III associated intra-5' UTR ORF in HCo V­
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-22 .3  kcal/mole 
Fig. A. 1 .  Potential stem-loop III analogs in PEDV and in HCoV-SARS 
predicted by the Zuk.er mfold alogrithm. AUG codons for potential 
stem-loop III associated ORFs are boxed. 
1 26 
NON REPLICATING MUTANTS OF STEM-LOOPS III AND IV SHOW 
DECREASED LEVELS OF NEGATIVE-STRAND RNA SYNTHESIS 
Stem-loop III has been proposed to function as a cis-acting element in the 
synthesis of both negative and positive-strand RNA (Chapter III of this 
dissertation), and stem-loop IV has been proposed to function as a cis-acting 
element in the synthesis of negative-strand RNA (Chapter IV of this dissertation). 
Therefore, to test the hypothesis that both stem-loops III and IV function as cis­
acting elements in negative-strand RNA synthesis, all the stem-loop III and IV 
mutants tested for replication (or positive-strand synthesis by Northern assays) 
were tested for negative-strand RNA synthesis by RNase protection assays. 
Briefly, a uniformly labeled 237 nt RNA probe containing nts 1 0 1 1 to 
1 1 97 of BCoV DI RNA positive-strand was generated as described in the RNase 
protection assay protocol. Therefore, the probe used had 1 86 nts that were 
specific to BCoV DI RNA and 51  nts of vector sequence. Besides this, part of the 
sequence that the probe was specific to was the 30-nt reporter sequence in the DI 
RNA that was not present in the wild type helper virus. The 30-nt sequence made 
it possible to distinguish between DI RNA and helper virus negative strands. This 
probe was used in a two-cycle RNase protection assay to assay for DI RNA 
negative-strand synthesis at 6 hours post transfection (Fig. A.2). A band 
migrating at the 1 86-nt position ( corresponding to the region of the probe that was 
protected from RNase digestion) was apparent with RNA from cells transfected 
with wild type DI RNA (lane 1 6), but not with RNA from infected, mock­
infected, or transfected but not infected cells (lanes 19, 1 8, and 1 7, respectively). 
Stem-loop III non-replicating mutants (Chapter III, Table 3. 1 )  pSLIII-mut2L (lane 
1 5), pSLIII-mut2R (lane 14), pSLIII-mutGU (lane 4), and pSLIII-mutCA (lane 5) 
showed lower levels of negative strand synthesis (lower levels of the 1 86-nt band) 
than wild type DI RNA (lane 16) or stem-loop III replicating mutant pSLIII­
mut2L/R (lane 1 3). Interestingly, the stem-loop III associated ORF mutant 
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Fig. A.2. Nonreplicating mutants of stem-loops III and IV show 
decreased levels of negative-strand RNA synthesis by the RNase 
protection assay. Lanes 1 and 20, molecular weight markers; lane 2, 
pSLIV-mutCA; lane 3, pSLIV-mutGU; lane 4, pSLIIl-mutGU; lane 5, 
pSLIII-mutCA; lane 6, pSLIV-mut7; lane 7, pSLIV-mutDel; lane 8, 
pSLIV-mutL/R; lane 9, pSLIV-mutR; lane 1 0, pSLIV-mutL; lane 11 , 
pSLIII-mut3L; lane 12, pSLIII-mut4L/R; lane 13, pSLIII-mut2L/R; 
lane 14, pSLIII-mut2R; lane 15, pSLIII-mut2L; lane 16, wild type DI 
RNA; lane 17, RNA from transfected but not infected cells; lane 18, 
mock-infected cells; lane 19, infected cells; lane 21, 5 X 105 cpm of 
undigested probe. 
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ORF mutant pSLIII- mut3L that did replicate (lane 1 1 ) showed near wild type 
levels of negative-strand synthesis. The stem-loop IV non-replicating mutants 
(Chapter IV, Table 4.1 )  pSLIV-mutL (lane 1 0), pSLIV-mutR (lane 9), pSLIV­
mutDel (lane 7), pSLIV-mut7 (lane 6), and pSLIV-mutCA (lane 2) showed lower 
levels of negative-strand synthesis than wild type DI RNA (lane 1 6) or stem-loop 
IV replicating mutants pSLIV-mutL/R (lane 8), and pSLIV-mutGU (lane 3). 
Though these results hint at the possibility that stem-loops III and IV 
might function in negative-strand RNA synthesis, it is not known at this time 
whether the negative strands that were detected in the mutants had maintained 
their mutant sequences or if they had reverted to wild type sequence. Further 
examination of mutant negative-strand sequences, as well as assays for negative­
strand synthesis at different time points post transfection need to be done to better 
understand the role of stem-loops III and IV in negative-strand synthesis. 
RNASE PROTECTION ASSAY PROTOCOL 
To generate the minus-strand RNA probe, plasmid derivative pDrepRP A 
was constructed by overlap PCR mutagenesis in which primers pDrep 1 ( 1 1 88)( +) 
(which binds to nts 1 1 80 through 1208 of pDrepl DNA and had sequence: 
GGAGAGGATCCGGTTCTGTTGCCAGAATT) and pDrepl(l 1 1 1 )(-) (which 
binds to nts 984 through 1 028 and had sequence : 
CGATCGGT ACCT A TTCCGACT AGGTTTCC), and pDrep 1 DNA were used to 
make a 208 nt product that had a BamHl restriction endonuclease site at nt 1 1 97 
and a Kpnl site at nt 10 1 1. The 208-nt PCR product was trimmed to 1 86 nts with 
enzymes BamHl and KpnI, and cloned into BamHl/KpnI-linearized pGEM3Z 
vector. pDrepRPA DNA was linearized with Hind III restriction endonuclease 
and transcribed with T7 RN A polymerase in a 50 ul reaction volume in the 
presence of a32P-UTP (300 Ci/mmol). Transcripts were 23 7 nts in length and 
were purified by electrophoresis on an 8 M urea/6% polyacrylamide gel. 
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The two cycle RNase protection assays followed the procedures of Novak 
and Kirkegaard (Novak et al. , 1 99 1 ). Briefly, cells at 80% confluency in 35mm 
diameter dishes were infected with BCo V at a multiplicity of 1 0  PFU per cell and 
transfected with 500 ng of DI RNA transcript in Lipofectin at 1 hpi. For the first 
cycle of the RNase protection assay, RNA extracted from one 35mm dish by the 
NP-40-proteinase K method (yielding approximately 1 0  ug per dish) was 
resuspended in 30 ul of hybridization buffer (40 mM PIPES, 400 niM NaCl, 1 
mM EDT A, 80% formamide ), denatured at 85°C for 5 minutes and then 
hybridized overnight at 45°C. RNase digestion was then carried out by adding 
300 ul of RNase mix buffer ( 1 0  mM Tris-Cl pH 7.5, 1 M NaCl, 5 mM EDTA, 1 05 
U RNase Tl ,  and 2.6 U RNase A (Ambion) and incubation at 25°C for 1 hour. 
The samples were then subjected to phenol chloroform treatment and ethanol 
precipitation. In the second cycle, the RNA from the first cycle was resuspended 
in 30 ul of hybridization buffer and 5 x 1 05 cpm of the 32P-UTP labeled probe was 
added to this. After denaturation of the samples at 85°C for 5 minutes, 
hybridization of the probe to the negative strand RNA was carried out overnight 
at 45°C. RNase digestion of the samples was then carried out by adding 300 ul of 
RNase mix buffer and incubation at 25°C for 1 hour. After phenol chloroform 
extraction, the RNA was separated on a DNA sequencing gel of 6% 
polyacrylamide. 
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DETAILED PROTOCOL FOR ELECTROPHORETIC MOBILITY SHIFT 
ASSAY 
PREPARATION OF CELL L YSATES 
Freshly confluent HRT cells in 35 mm diameter dishes were either mock 
infected or infected with 200 ul of BCoV. At 6 hpi, cells were washed once with 
ice cold phosphate buffered saline and then harvested by scraping with the broad 
end of a blue tip and transferred to an Eppendorf tube. Cells were then 
centrifuged for 4 minutes at 600 X g and 4 °c. The supernatant was discarded and 
the cell pellet was then resuspended by vortexing in approximately 4 packed cell 
volumes of lysis buffer (5 mM HEPES [pH 7.9], 25 mM KCl, 2 mM MgCh, 4% 
glycerol, 20 mM DTT, 0.1 mM PMSF, 0.2 mM EDTA, 1 % [v/v] NP-40), kept on 
ice for 20 minutes, then transferred to a douncer, and homogenized by douncing 
with 30 strokes in a tight-fitting Dounce homogenizer. The lysate was transferred 
to an Eppendorf tube and nuclei were removed from the lysate by centrifugation 
at 700 X g for 10  minutes at 4°C. The supernatant was transferred to a fresh 
Eppendorf tube (this is the lysate that will be used for EMSA), and the pellet 
containing the nuclei was discarded. Total protein in the lysate was quantitated 
with the Bradford kit from BioRad according to the instructions in the kit. The 
lysate was then diluted if necessary with lysis buff er and divided into 10 ul 
aliquots containing 20 ug total protein each and stored at -80° C until use. 
SYNTHESIS OF RADIOLABELED RNA PROBE AND COLD 
COMPETITOR RNA 
For synthesis of the radiolabeled RNA probes and cold competitor RNA, 
wild type stem-loop IV-containing plasmid construct pSLIV(PB) was linearized 
with Nco I and stem-loop III containing plasmid construct pSLIII(PB) was 
linearized with Avril. Transcription of cold competitor RNA, using T7 RNA 
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polymerase was carried out and the transcripts were chromatographed through 
Biospin 6 columns and stored at -20°C until use. 
Transcription of radiolabeled RNA probe was carried out in a 50 ul 
volume by mixing together 1 0  ul of 5 X Transcription buffer, 5 ul of 1 00 mM 
DTT, 2.5 ul of acetylated BSA (2 mg/ml), 1.25 ul of RNasin ( 40 U/ul), 1 0  ul of 
rNTP mix (2.5 mM each of rATP, rGTP, rCTP), 2.5 ug of linearized DNA, 1 ul of 
T7 RNA polymerase (40 U), 6 ul of 1 00 uM UTP, and 12  ul of a32P-UTP (300 
Ci/mmol). Transcription was carried out for one hour at 37°C. After one hour 2.5 
U of RQ RNase free DNase ( 1  U/ul) was added to the transcription reaction, and 
the reaction was incubated for 30 minutes at 37°C. The reaction was phenol 
chloroform extracted once, and 50 ul of sequencing stop dye was added and the 
components were electrophoretically separated on an 8 M urea, 6% PAGE gel. 
The gel was exposed to X ray film for 1 0  minutes to determine the position of the 
probe on the gel and the region of the gel containing the probe was cut out and 
placed into a 1 5  ml conical tipped tube. The probe was eluted in elution buffer 
(0.5 M ammonium acetate, 1 mM EDT A) overnight with constant rotation at 4°C. 
The probe was then ethanol precipitated and resuspended in 20 ul of water and the 
radioactive content of the probe was measured by Cerenkov counting. The probe 
was then diluted to 2 X 104 cpm/ul, cerenkov counts. 
RNA-PROTEIN BINDING REACTION 
For the EMSA, the 32 P-UTP labeled probe and unlabeled competitor 
RNAs were renatured separately. For this, approximately 10 ul of RNA (2 X 1 04 
cpm/ul of probe) was added to 1 0  ul of 2 X renaturation buffer ( 40 mM HEP ES 
[pH 7.9] , 1 20 mM KCl, 4 mM MgCh), and the mixture was incubated for 30 
minutes at 45° C. In the meantime, the cell lysates in 10  ul aliquots were thawed 
on ice, and 1 0  ug yeast tRNA in 1 ul, lul of 1 00 mM PMSF, and 1 ug heparin in 1 
ul were added to the lysate. Cold competitor RNA was added in certain 
experiments. This mixture was preincubated without the RNA probe for 1 0  
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minutes at 30° C, then 1 ul of the renatured probe ( 1  X 104 cpm of 32P-UTP 
labeled probe) was added to the mixture and the mixture was incubated at 30° C 
for 10 min. 2 ul of 50% glycerol was then added, and the products were 
electrophoretically separated on a 6% native polyacrylamide/5% glycerol gel at 4° 
C using 0.5 X TBE ( 1  X is 0.09 M Tris, 0.09 M boric acid, 0.002M EDT A) as 
electrophoresis buffer. 
For UV cross-linking and molecular weight determinations the RNA­
protein binding reaction mixtures, before the addition of glycerol, were irradiated 
at 3 mwatts/cm2 on ice for 30 minutes in a Stratalinker UV cross linker 1 800 and 
the preparation was digested with 100 U of RNase Tl, 2.5 U of RNase A and 1 U 
of RNase CV 1 (Ambion) for 40 minutes at 3 7° C. After digestion, equal volumes 
of SDS-PAGE loading dye was added to the samples and the products were 
electrophoretically separated on an SDS PAGE gel of 10% polyacrylamide. Gels 
were dried and analyzed with a Packard Instantlmager Autoradiography System 
and exposed to Kodak XAR-5 film for 1 to 10 days at -80°C for imaging. Images 
were recorded by digital scanning of the film. 
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